<SEC-DOCUMENT>0001193125-24-152389.txt : 20240603
<SEC-HEADER>0001193125-24-152389.hdr.sgml : 20240603
<ACCEPTANCE-DATETIME>20240603080401
ACCESSION NUMBER:		0001193125-24-152389
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20240602
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240603
DATE AS OF CHANGE:		20240603

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COHERENT CORP.
		CENTRAL INDEX KEY:			0000820318
		STANDARD INDUSTRIAL CLASSIFICATION:	OPTICAL INSTRUMENTS & LENSES [3827]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				251214948
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39375
		FILM NUMBER:		241012039

	BUSINESS ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056
		BUSINESS PHONE:		724-352-4455

	MAIL ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	II-VI INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d845190d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cohr="http://imetrix.edgar-online.com/20240602" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-387">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-06-02_to_2024-06-02">0000820318</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cohr-20240602.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-06-02_to_2024-06-02"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000820318</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-06-02</xbrli:startDate> <xbrli:endDate>2024-06-02</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-398">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-06-02_to_2024-06-02" format="ixt:datemonthdayyearen" id="ixv-399">June 2, 2024</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-400">Coherent Corp.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-06-02_to_2024-06-02" format="ixt-sec:stateprovnameen" id="ixv-401">Pennsylvania</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-402">001-39375</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-403">25-1214948</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br/>of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:99%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-404">375 Saxonburg Boulevard</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-405">Saxonburg</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-06-02_to_2024-06-02" format="ixt-sec:stateprovnameen" id="ixv-406">Pennsylvania</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-407">16056</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices) (Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-408">(724)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-409">352-4455</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-06-02_to_2024-06-02" format="ixt-sec:boolballotbox" id="ixv-410">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-06-02_to_2024-06-02" format="ixt-sec:boolballotbox" id="ixv-411">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-06-02_to_2024-06-02" format="ixt-sec:boolballotbox" id="ixv-412">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-06-02_to_2024-06-02" format="ixt-sec:boolballotbox" id="ixv-413">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-414">Common Stock, no par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-415">COHR</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-06-02_to_2024-06-02" format="ixt-sec:exchnameen" id="ixv-416">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-06-02_to_2024-06-02" format="ixt-sec:boolballotbox" id="ixv-417">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;5.02 &#8195;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">On February&#160;20, 2024, Coherent Corp. (the &#8220;Company&#8221;) filed a Current Report on Form <span style="white-space:nowrap">8-K</span> announcing that Dr.&#160;Vincent&#160;D. Mattera, Jr., the Chief Executive Officer (&#8220;CEO&#8221;) of the Company, had informed the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) of his intent to retire as CEO following the appointment of his successor (or otherwise at the end of calendar 2024). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">On June&#160;3, 2024, the Company announced the appointment of James R. Anderson as CEO of the Company, effective June&#160;3, 2024 (the &#8220;Start Date&#8221;), to replace Dr.&#160;Mattera as CEO. In compliance with his CEO Succession and Retirement Agreement dated February&#160;17, 2024, Dr.&#160;Mattera resigned as a Class&#160;One member of the Board immediately before the Start Date, and Mr.&#160;Anderson was elected as a Class&#160;One member of the Board replacing Dr.&#160;Mattera effective on the Start Date. Dr.&#160;Mattera will receive the payments and benefits contemplated by the CEO Succession and Retirement Agreement, as previously disclosed and filed as Exhibit 10.1 to the Current Report on Form <span style="white-space:nowrap">8-K</span> filed on February&#160;20, 2024. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">Mr.&#160;Anderson, age 51, served as a director and as President and Chief Executive Officer of Lattice Semiconductor Corporation (&#8220;Lattice&#8221;) since September 2018. Prior to joining Lattice, Mr.&#160;Anderson served as the Senior Vice President and General Manager of the Computing and Graphics Business Group at Advanced Micro Devices, Inc. (&#8220;AMD&#8221;). Prior to AMD, Mr.&#160;Anderson held a broad range of leadership positions spanning general management, engineering, sales, marketing, and corporate strategy at companies including Intel, Broadcom (formerly Avago Technologies), and LSI Corporation. Mr.&#160;Anderson has served on the board of directors of Entegris, Inc. since March 2023, and he currently serves on the board of directors of the Semiconductor Industry Association. Mr.&#160;Anderson previously served on the board of directors of Sierra Wireless from April 2020 to January 2023. Mr.&#160;Anderson earned an MBA and Master of Science in electrical engineering and computer science from the Massachusetts Institute of Technology, a Master of Science in electrical engineering from Purdue University, and a Bachelor of Electrical Engineering from the University of Minnesota. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">There are no arrangements or understandings between Mr.&#160;Anderson and any other persons pursuant to which Mr.&#160;Anderson was appointed CEO or a director. Mr.&#160;Anderson does not have any family relationship with any of the Company&#8217;s directors or executive officers or any persons nominated or chosen by the Company to be a director or executive officer. Mr.&#160;Anderson has no direct or indirect material interest in any transaction or proposed transaction required to be reported under Item 404(a) of <span style="white-space:nowrap">Regulation&#160;S-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">In connection with his appointment as CEO, Mr.&#160;Anderson entered into an offer letter agreement with the Company (the &#8220;Offer Letter&#8221;) on May&#160;31, 2024 effective on the Start Date. Pursuant to the Offer Letter, Mr.&#160;Anderson will serve as CEO, will be elected as a member of the Board as of the Start Date, and will be recommended for election as a member to the Board at future shareholder meetings in which Class&#160;One directors are elected as long as he is CEO. The Offer Letter does not have a specific term and provides that Mr.&#160;Anderson will be an <span style="white-space:nowrap">at-will</span> employee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">The Offer Letter provides as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:justify">Mr.&#160;Anderson&#8217;s annual base salary will be $1,060,000, subject to increase, but not decrease, based on an annual review by the Board&#8217;s Compensation and Human Capital Committee. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:justify">Mr.&#160;Anderson will be eligible to earn annual incentive compensation awards beginning for fiscal year 2025, subject to the terms and conditions of the Company&#8217;s annual incentive plans, with a target annual bonus of 150% of his base salary. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:justify">Mr.&#160;Anderson will be eligible to receive long-term incentive awards under the Coherent Corp. Omnibus Incentive Plan consistent with the design for the Company&#8217;s other executive officers. For fiscal year 2025, the aggregate target grant date value of the long-term incentive awards for Mr.&#160;Anderson equals $12,000,000, provided 40% as time-vesting restricted stock units (&#8220;RSU&#8221;) and 60% as performance stock units (&#8220;PSUs,&#8221; together with the &#8220;RSUs,&#8221; the &#8220;Fiscal Year 2025 Awards&#8221;). However, as an inducement to his acceptance of the Company&#8217;s offer of employment, the fiscal year 2025 RSUs and PSUs will be granted on the Start Date as part of his <span style="white-space:nowrap">sign-on</span> inducement equity awards as described below. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:justify">Mr.&#160;Anderson will receive a cash <span style="white-space:nowrap">sign-on</span> bonus in the amount of $500,000 to be paid in a lump sum on the first regular payroll date following the Start Date. If Mr.&#160;Anderson&#8217;s employment with the Company terminates before the second anniversary of the Start Date either by his voluntary resignation other than for &#8220;good reason&#8221; or by the Company for &#8220;cause&#8221; (as such terms are defined in the Offer Letter), then Mr.&#160;Anderson will be required promptly repay to the Company the full gross amount of the <span style="white-space:nowrap">sign-on</span> bonus. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:justify">Mr.&#160;Anderson will receive new hire equity awards effective on the Start Date as an inducement to Mr.&#160;Anderson accepting the Company&#8217;s offer of employment. The inducement equity awards will be in the total amount of $48,000,000, of which $12,000,000 represents the value of the Fiscal Year 2025 Award and $36,000,000 represents <span style="white-space:nowrap">sign-on</span> awards in part to recognize equity awards that Mr.&#160;Anderson will forfeit from Lattice (the <span style="white-space:nowrap">&#8220;Sign-On</span> Awards,&#8221; together with the Fiscal Year 2025 Awards, the &#8220;Inducement Awards&#8221;). The material features of the Inducement Awards are as follows: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:justify">$8,400,000 of the total award value (representing 40% of the Fiscal Year 2025 Awards value and 10% of the <span style="white-space:nowrap">Sign-On</span> Awards value) will be delivered as an award of time-vesting RSUs. The number of such RSUs will be determined based on the <span style="white-space:nowrap">30-day</span> trailing average of the market price of the Company&#8217;s common stock immediately prior to the Start Date (rounded up to the next whole share), with annual vesting over three years starting on the first anniversary of the Start Date. </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:justify">The remaining $39,600,000 of the total award value (representing 60% of the Fiscal Year 2025 Awards value and 90% of the <span style="white-space:nowrap">Sign-On</span> Awards value) will be delivered as an award of PSUs. The target number of PSUs will be determined based on the <span style="white-space:nowrap">30-day</span> trailing average of the market price of the Company&#8217;s common stock immediately prior to the Start Date (rounded up to the next whole share). The PSUs will be earned over an approximate <span style="white-space:nowrap">3-year</span> performance period (beginning on the Start Date and ending on the last day of fiscal year 2027) based on relative total shareholder return (&#8220;rTSR&#8221;) performance similar to the Company&#8217;s fiscal year 2024 rTSR PSU awards, but with (i)&#160;target (100%) payout set at 55th percentile achievement, and (ii)&#160;the maximum payout (at the 75th percentile achievement or better) providing a 250% payout. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:justify">The Inducement Awards will have vesting treatment on termination of employment or &#8220;change in control&#8221; (as defined in the Coherent Corp. Omnibus Incentive Plan) consistent with the Company&#8217;s standard terms for executive officers, as modified by the Offer Letter as described below. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:justify">The Inducement Awards will be granted outside of the Coherent Corp. Omnibus Incentive Plan as stand-alone inducement awards as permitted by Section&#160;303A.08 of the New York Stock Exchange&#8217;s listing rules (and subject to compliance with those listing rules). Each award will be documented by an award agreement substantially in the forms attached as exhibit to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:justify">Mr.&#160;Anderson will be eligible to participate in the Company&#8217;s employee benefit plans generally available to senior executives of the Company. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">Upon Mr.&#160;Anderson&#8217;s termination of employment without cause or voluntary resignation for good reason, then, subject to his timely execution and <span style="white-space:nowrap">non-revocation</span> of a release of claims, he will be eligible to receive severance payments and benefits set forth in the Offer Letter that are generally consistent with the terms of the Company&#8217;s Executive Severance Plan, except that the amounts will be based on a 2x multiple for a &#8220;Qualifying Termination&#8221; during a <span style="white-space:nowrap">&#8220;Non-CIC</span> Period&#8221; and a 3x multiple during a &#8220;CIC Period&#8221; (as those terms are defined in the Offer Letter). In case of a Qualifying Termination during a <span style="white-space:nowrap">Non-CIC</span> Period, the inducement PSUs will be determined based on rTSR performance through the date of termination and immediately paid out on a prorated basis (after credit for an additional 12 months of service) at the greater of target or actual performance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">The Offer Letter includes restrictive covenants consistent with those applicable under the Executive Severance Plan, but excluding covenants related to not competing with the Company and not soliciting Company customers. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">The description of the Offer Letter and Inducement Awards as summarized above is qualified in its entirety by reference to the copy of the full text of the Offer Letter and forms of award agreements for the Inducement Award RSUs and PSUs, which are filed as Exhibits 10.1, 10.2, and 10.3, respectively, to this Current Report <span style="white-space:nowrap">on&#160;Form&#160;8-K&#160;and&#160;which</span> are incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;7.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">A copy of the press release regarding this announcement of Mr.&#160;Anderson&#8217;s appointment and Dr.&#160;Mattera&#8217;s retirement is furnished as Exhibit&#160;99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated into this Item 7.01 by reference thereto. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">The information in Item 7.01 to this Current Report <span style="white-space:nowrap">on&#160;Form&#160;8-K,&#160;including&#160;the</span> exhibit furnished pursuant to Item 99.1, shall not be deemed &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities under that Section. Furthermore, the information in this Item 7.01 of this Current Report <span style="white-space:nowrap">on&#160;Form&#160;8-K,&#160;including&#160;the</span> exhibit furnished pursuant to Item 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, the Exchange Act, regardless of any general incorporation language contained in such filing. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:6%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d845190dex101.htm">Offer Letter between James R. Anderson and Coherent Corp. dated May&#160;31, 2024 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d845190dex102.htm">Form of Award Agreement for Inducement RSUs </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d845190dex103.htm">Form of Award Agreement for Inducement PSUs </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d845190dex991.htm">Press Release dated June&#160;3, 2024 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104.0</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Coherent Corp.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: June&#160;3, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ronald Basso</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Ronald Basso</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Legal and Compliance Officer<br/>&amp; Corporate Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d845190dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g845190dsp_5.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">375 Saxonburg Blvd.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Saxonburg, PA
16056-9499</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">USA</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Execution Copy </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;31,
2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James R. Anderson </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Dear Jim, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On behalf of Coherent Corp. (the &#147;Company,&#148; &#147;we&#148; or &#147;us&#148;), I am pleased to confirm with you the terms of our
offer of employment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Start Date, Position and Duties</U>. Your start date will be June&nbsp;3, 2024, or such other date as we
may mutually agree (the &#147;Start Date&#148;). You will serve as the Company&#146;s Chief Executive Officer reporting to the Company&#146;s Board of Directors (the &#147;Board&#148;), with duties and authority consistent with such position and the
Company&#146;s Bylaws. You will also be appointed to the Board as a Class&nbsp;One director effective on the Start Date. We will cause your nomination for election to the Board for future years while you serve as Chief Executive Officer.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You will be permitted to perform your duties from your current location in California (i.e., no
relocation to Pennsylvania is required), subject to reasonable business travel consistent with your duties as the Chief Executive Officer of a globally operating public company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During your employment, you will: (i)&nbsp;devote substantially all your working time and attention to the business and
affairs of the Company (excluding any vacation, sick leave or other approved leave to which you are entitled), render such services to the best of your ability, and use your reasonable best efforts to promote the interests of the Company,
(ii)&nbsp;not engage in any other employment, consulting or other business activity that would create a conflict of interest with your services to the Company, (iii)&nbsp;not assist any person or entity in competing with the Company or in preparing
to compete with the Company and (iv)&nbsp;comply with the Company&#146;s policies and rules, as they may be in effect from time to time. Notwithstanding the foregoing, you will be entitled to: (A)&nbsp;serve on the boards of organizations (both for
profit or <FONT STYLE="white-space:nowrap">non-profit),</FONT> subject to the Board&#146;s prior consent, not to be unreasonably withheld or delayed, (B)&nbsp;serve on civic or charitable boards or committees, (C)&nbsp;deliver lectures or fulfill
speaking engagements, and (D)&nbsp;manage personal investments, so long as, in each such case, such activities do not (x)&nbsp;significantly interfere with the performance of your responsibilities as an employee of the Company, or (y)&nbsp;create a
conflict of interest with your services to the Company. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Employment-at-Will</FONT></FONT></U>.
Your employment with the Company will be <FONT STYLE="white-space:nowrap">at-will.</FONT> This means either you and/or the Company will be free to terminate this employment relationship at any time, with or without cause. Any such termination will
require 30 days&#146; advance written notice to the other party, provided that the Company may terminate your employment immediately for &#147;Cause&#148; (as defined below). </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U><FONT STYLE="white-space:nowrap">Sign-On</FONT> Bonus and Initial Equity Award</U>. You will receive the
following awards effective on the Start Date. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">You will receive a <FONT STYLE="white-space:nowrap">sign-on</FONT> bonus in the gross amount of $500,000,
payable in a single cash payment (after required tax withholdings) on the first regular payroll date following the Start Date. Should you voluntarily resign your position other than for &#147;Good Reason&#148; (as defined below) or should the
Company terminate your employment for Cause, in either case prior to the second anniversary of the Start Date, you will be required to promptly repay the full gross amount of the <FONT STYLE="white-space:nowrap">sign-on</FONT> bonus.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Effective on the Start Date and as an inducement to your acceptance of this offer, you will receive two
inducement equity awards in the total amount of $48,000,000, of which $12,000,000 represents the value of the Company&#146;s FY25 awards and $36,000,000 represents a <FONT STYLE="white-space:nowrap">sign-on</FONT> award (in part to recognize equity
awards you will forfeit from your current employer). The inducement equity awards will be delivered as follows: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">$8,400,000 of the total award value (representing 40% of the FY25 annual award value and 10% of the
additional <FONT STYLE="white-space:nowrap">sign-on</FONT> award value)) will be delivered as an award of time-vesting restricted stock units (the &#147;Inducement RSUs&#148;). The number of Inducement RSUs will be determined based on the <FONT
STYLE="white-space:nowrap">30-day</FONT> trailing average of the market price of the Company&#146;s common stock immediately prior to the Start Date (rounded up to the next whole share), with annual vesting over three years starting on the first
anniversary of the Start Date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The remaining $39,600,000 of the total award value (representing 60% of the FY25 annual award value plus 90%
of the additional <FONT STYLE="white-space:nowrap">sign-on</FONT> award value) will be delivered as an award of performance stock units (the &#147;Inducement PSUs&#148;). The target number of Inducement PSUs will be determined based on the <FONT
STYLE="white-space:nowrap">30-day</FONT> trailing average of the market price of the Company&#146;s common stock immediately prior to the Start Date (rounded up to the next whole share). The Inducement PSUs will be earned over an approximate <FONT
STYLE="white-space:nowrap">3-year</FONT> performance period (beginning on the Start Date and ending on the last day of FY27) based on relative total shareholder return (&#147;rTSR&#148;) performance similar to the Company&#146;s FY24 rTSR PSU
awards, but with (i)&nbsp;target (100%) payout set at 55th percentile achievement, and (ii)&nbsp;the maximum payout (at the 75th percentile achievement or better) providing a 250% payout. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Each of the inducement equity awards will have vesting treatment on termination of employment or change in
control consistent with the Company&#146;s standard terms for executive officers, as modified by Section&nbsp;4(e) below. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">iv.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The inducement equity awards will be granted outside of the Company&#146;s shareholder-approved equity
compensation plan as stand-alone inducement awards as permitted by Section&nbsp;303A.08 of NYSE&#146;s listing rules (and subject to compliance with those listing rules). Each award will be documented by an award agreement substantially in the forms
attached to this offer letter as <U>Exhibits A</U> and <U>B</U>, which in all cases will control except to the extent any provisions in <U>Exhibit C</U> related to equity vesting are more favorable to you. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Ongoing Compensation and Benefits</U>. We will provide you with the following compensation and benefits
during your employment: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Base Salary</I>. You will receive base salary at the annual rate of $1,060,000, payable in accordance
with the Company&#146;s regular payroll practices. At least annually beginning in August 2025, the Compensation and Human Capital Committee of the Board (the &#147;Committee&#148;) will consider whether, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
in its discretion, to increase, but not decrease, your rate of base salary, based on market trends, internal considerations, performance or such other factors as the Committee may determine.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Annual Incentive Compensation</I>. You will have a target annual incentive award for FY25 equal to 150%
of your base salary (i.e., target award of $1,590,000), delivered in the same form and on the same terms as determined for the Company&#146;s other executive officers for FY25, including in a combination of awards under the Bonus Incentive Plan
(with a target equal to 8% of your salary) and Goals Results Incentive Program (for the balance of the target and which may include a combination of financial and strategic performance goals). Your target annual incentive award for years after FY25
will not be less than 150% of your base salary as then in effect. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Long-Term Incentive Awards</I>. You will receive annual long-term incentive awards in such value as
determined by the Committee and in such mix and on such terms as the Committee may determine, consistent with the design for the Company&#146;s other executive officers. The total award value for the FY25 awards is $12,000,000; however, as an
inducement to your acceptance of this offer, your FY25 awards will be made as part of your <FONT STYLE="white-space:nowrap">sign-on</FONT> inducement equity awards granted on your Start Date as described above. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Benefits</I>. You will be entitled to participate in all retirement, health and welfare, vacation and
other benefit plans and arrangements generally available to other senior executives of the Company in accordance with the terms and provisions of such plans, other than the Company&#146;s Executive Severance Plan. <U></U> </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Severance Protection</I>. In lieu of participation in the Executive Severance Plan, you shall have the
severance protection set forth in <U>Exhibit C</U> to this offer letter. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Business Expenses</I>. We will reimburse you for reasonable and necessary travel and accommodation costs,
entertainment and other business expenses incurred as a necessary part of discharging your duties hereunder, subject to our standard expense reimbursement policies. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Covenants.</U> You will be subject to the restrictive covenants set forth in Section&nbsp;7 of <U>Exhibit
C</U> to this offer letter regarding confidential information, inventions, and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> of employees. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Indemnification</U>. The Company will indemnify you and hold you harmless to the fullest extent permitted
by law against and in respect of any and all actions, suits, proceedings, claims, demands, judgments, costs, expenses (including advancement of reasonable attorney&#146;s fees), losses, and damages resulting from your good faith performance of your
duties and obligations with the Company (but exclusive of any claims made by you or on your behalf). The Company will provide you with an Indemnification Agreement in the same form applicable to other executive officers of the Company to be executed
by you on or before the Start Date, and the Company will cover you under the Company&#146;s directors&#146; and officers&#146; liability insurance both during and, while potential liability exists, after employment in the same amount and to the same
extent as the Company covers its other officers and directors. These obligations will survive the termination of your employment with the Company. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Miscellaneous.</U> </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>No Conflicts</I>. By signing this letter, you represent to the Company that your acceptance of this offer
and agreement to accept employment with the Company under these terms will not conflict with, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
violate or constitute a breach of any employment or other agreement to which you are a party and that you are not required to obtain the consent of any person, firm, corporation or other entity
in order to accept this offer of employment. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Successors and Assigns</I>. This letter shall inure to the benefit of and be binding upon (i)&nbsp;the
Company and its successors and assigns and (ii)&nbsp;you and your heirs and legal representatives, except that your duties and responsibilities under this letter that are of a personal nature and will not be assignable or delegable in whole or in
part without our prior written consent. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Entire Agreement</I>. This letter, including each exhibit, sets forth the entire present agreement of the
parties concerning the subjects covered herein. There are no promises, understandings, representations, or warranties of any kind concerning those subjects except as expressly set forth herein or therein. Any modification of this letter must be in
writing and signed upon the express consent of all parties. Any attempt to modify this letter, orally, or in writing not executed by all parties, will be void. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Enforceability</I>. If any provision of this letter, or its application to anyone or under any
circumstances, is adjudicated to be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability will not affect any other provision or application of this letter which can be given effect without the invalid or unenforceable
provision or application and will not invalidate or render unenforceable such provision or application in any other jurisdiction. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Governing Law</I>. This letter shall be governed and interpreted in accordance with the laws of the
Commonwealth of Pennsylvania without regard to the state&#146;s conflict of laws provision. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Waivers</I>. No failure on the part of any party to enforce any provisions of this letter will act as a
waiver of the right to enforce that provision. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">g.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Withholding</I>. All payments of compensation due to you by the Company shall be net of any tax or other
amounts required to be withheld by the Company under applicable law. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">h.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Section 409A</I>. This letter is intended to comply with Section&nbsp;409A of the Internal Revenue Code
of 1986, as amended (the &#147;Code&#148;) or an exemption thereto, and, to the extent necessary in order to avoid the imposition of an additional tax on you under Section&nbsp;409A of the Code, payments may only be made under this letter upon an
event and in a manner permitted by Section&nbsp;409A of the Code. Any payments or benefits that are provided upon a termination of employment shall, to the extent necessary in order to avoid the imposition of any additional tax on you under
Section&nbsp;409A of the Code, not be provided unless such termination constitutes a &#147;separation from service&#148; within the meaning of Section&nbsp;409A of the Code. Any payments that qualify for the &#147;short term deferral&#148; exception
or another exception under Section&nbsp;409A of the Code shall be paid under the applicable exception. Notwithstanding anything in this letter to the contrary, if you are considered a &#147;specified employee&#148; (as defined in Section&nbsp;409A
of the Code), any amounts paid or provided under this letter due to your separation from service shall, to the extent necessary in order to avoid the imposition of an additional tax on you under Section&nbsp;409A of the Code, be delayed for six
months after your &#147;separation from service&#148; within the meaning of Section&nbsp;409A of the Code, and the accumulated amounts shall be paid in a lump sum within 10 calendar days after the end of the
<FONT STYLE="white-space:nowrap">6-month</FONT> period. If you die during the <FONT STYLE="white-space:nowrap">6-month</FONT> postponement period prior to the payment of benefits, any payment amount that was deferred on account of Section&nbsp;409A
of the Code shall be paid to the personal </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
representative of your estate within 60 calendar days after the date of your death. For purposes of Section&nbsp;409A of the Code, the right to a series of installment payments under this letter
shall be treated as a right to a series of separate payments. In no event may you, directly or indirectly, designate the calendar year of a payment. All reimbursements and in kind benefits provided under this letter shall be made or provided in
accordance with the requirements of Section&nbsp;409A of the Code, including, where applicable, the requirement that (i)&nbsp;any reimbursement is for expenses incurred during the period of time specified in this letter, (ii)&nbsp;the amount of
expenses eligible for reimbursement, or in kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement, or in kind benefits to be provided, in any other calendar year, (iii)&nbsp;the reimbursement of an
eligible expense will be made no later than the last calendar day of the calendar year following the year in which the expense is incurred, and (iv)&nbsp;the right to reimbursement or in kind benefits is not subject to liquidation or exchange for
another benefit. The Company makes no representations that the payments and benefits provided under this letter comply with Section&nbsp;409A of the Code and in no event shall the Company be liable for all or any portion of any taxes, penalties,
interest or other expenses that may be incurred by you on account of noncompliance with Section&nbsp;409A of the Code. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Amendment</I>. This letter, including each exhibit, may be amended or modified only by a written
instrument signed by you and by a duly authorized representative of the Company </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You acknowledge that you have received
and read copies of the Company&#146;s Stock Ownership Guidelines for Executive Officers and Other Key Executives and the Company&#146;s Clawback Policy, and you will sign the required acknowledgement form for the Clawback Policy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURES ON NEXT PAGE] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Jim, we are most enthusiastic about your joining the team. If these provisions are agreeable
to you, please sign one copy of this letter and return it to me as soon possible. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Sincerely,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Enrico DiGirolamo</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Enrico DiGirolamo</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Lead Independent Director, Coherent Corp.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ James R. Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">James R. Anderson</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A: Inducement Award RSU Award Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[separately filed] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit B: Inducement Award PSU Award Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[separately filed] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit C: Severance Protection </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Accrued Obligations</U>. If your employment terminates for any reason (by your action or the
Company&#146;s, with or without Cause), you shall receive the Accrued Obligations. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Qualifying Termination During a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period</U>. If you incur
a Qualifying Termination and your Date of Termination is during a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period, then, in addition to any Accrued Obligations, you shall be entitled to the following (which shall be payable in accordance with
Section&nbsp;4.1 below, other than as provided in Section&nbsp;2.3): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Cash Severance</U>. An amount equal to (A)&nbsp;the product of (i) 24 and (ii)&nbsp;your monthly rate of
Base Salary, plus (B)&nbsp;the Bonus that you would have earned had your employment continued through the end of the fiscal year in which the Qualifying Termination occurs, with such amount to be estimated reasonably and in good faith by the
Compensation and Human Capital Committee of the Board at the time of the Qualifying Termination based on the anticipated actual payout under the Company&#146;s BIP, GRIP and/or other applicable incentive bonus plan as of the end of the fiscal year
based on the performance of the Company and which estimate shall be evidenced by the Company&#146;s accrual for the same in the books of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Healthcare Coverage Payment</U>. An amount equal to the product of (i) 24 and (ii)&nbsp;the full total
monthly premium cost (i.e., yours and the Company&#146;s portion) for your Healthcare Coverage. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Equity Vesting</U>. All tranches of any outstanding Company equity awards (including, if applicable, the
Inducement RSUs and PSUs) with a vesting date within 12 months after your Date of Termination will fully vest and, if applicable, remain exercisable for the period set forth in the applicable equity award agreement. In addition, any vesting tranche
of such equity awards that began during your employment or during the first 12 months after your Date of Termination but was not completed by the first anniversary of your Date of Termination shall vest pro rata based on a fraction, the numerator of
which is the number of months within such vesting tranche you would have been employed if you had remained employed through the first anniversary of your Date of Termination, and the denominator of which is the total number of months in the vesting
tranche, or, for performance-based equity awards (including the Inducement PSUs), the total number of months in the performance period. For the avoidance of any doubt: (i)&nbsp;the payout for performance-based equity awards for a Qualifying
Termination during a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period will be based on actual performance during the entire performance period, then <FONT STYLE="white-space:nowrap">pro-rated</FONT> as provided in this Section&nbsp;2.3,
provided that for the Inducement PSUs, performance will be determined as of the Date of Termination and the payout will be based on the greater of target or actual performance, with the payout made as soon as practicable after the Release becomes
effective not more than 75 days after your Date of Termination; and (ii)&nbsp;the provisions of this Section&nbsp;2.3 shall supersede the provisions contained in the applicable equity award agreements, provided that the provisions of the equity
award agreements will control to the extent such provisions are more favorable to you. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Qualifying Termination During a CIC Period</U>. If you incur a Qualifying Termination and your Date of
Termination is during a CIC Period, then, in addition to any Accrued Obligations, you shall be entitled to the following (which shall be payable in accordance with Section&nbsp;4.2 below): </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Cash Severance</U>. An amount equal to (A)&nbsp;the product of (i) 36 and (ii)&nbsp;your monthly rate of
Base Salary, plus (B)&nbsp;the product of (i)&nbsp;the 3.0 and (ii)&nbsp;your Target Bonus Amount for the fiscal year of the Company in which the Date of Termination occurs. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Healthcare Coverage Payment</U>. An amount equal to the product of (i) 36 and (ii)&nbsp;the full total
monthly premium cost (i.e., yours and the Company&#146;s portion) for your Healthcare Coverage. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Equity Vesting</U>. Any unvested outstanding Company equity awards (including, if applicable, the
Inducement RSUs and PSUs) will become fully vested and, if applicable, each such equity award shall remain exercisable for the period set forth in the applicable equity award agreement. For the avoidance of any doubt, the provisions of this
Section&nbsp;3.3 shall supersede the provisions contained in the applicable equity award agreements, provided that the provisions of the equity award agreements will control to the extent such provisions are more favorable to you. In the case of any
performance-based equity awards (including the Inducement PSUs), &#147;full vesting&#148; means vesting based on the greater of: (A)&nbsp;an assumed achievement of all relevant performance goals at the &#147;target&#148; level, or (B)&nbsp;the
actual level of achievement of all relevant performance goals against target measured for the period commencing on the beginning of the relevant performance period for each such award through the date immediately preceding the Change in Control.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">3.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U><FONT STYLE="white-space:nowrap">Pro-Rata</FONT> Bonus</U>. An amount equal to a pro rata portion (based
on the number of days during the applicable performance year that you were employed by the Company) of your CIC Period Bonus. In addition, if the Bonus for the performance year immediately preceding your Date of Termination had not yet been paid,
you shall receive 100% of the Bonus, if any, for such immediately preceding performance period that would otherwise have been paid to you (without the application of any negative discretion) if your employment had not so terminated, payable at the
same time as such Bonus is paid to other Company employees. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Time and Form of Payments</U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Payments for a Qualifying Termination During a <FONT STYLE="white-space:nowrap">Non-CIC</FONT>
Period</U>. The amount contemplated under Section&nbsp;2.1 and Section&nbsp;2.2 shall be paid in a lump sum cash in the next pay period after the Release becomes effective (not more than 75 days after your Date of Termination). In both cases, the
payments described shall be conditioned on you providing the Company with (and not revoking) a Release, no later than 60 days after your Date of Termination. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Payments for a Qualifying Termination During a CIC Period</U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">4.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>General</U>. Other than as provided in Section&nbsp;4.2.2 below, the amounts contemplated under
Section&nbsp;3.1 and Section&nbsp;3.2 shall be paid in a lump sum cash payment in the next pay period after the Release becomes effective (not more than 75 days after your Date of Termination). The amount of the CIC Period Bonus based on those
portions of the formula that are knowable at such time shall be paid in a lump sum cash payment in the next pay period after the Release becomes effective (not more than 75 days after your Date of Termination) and if the CIC Period Bonus is
determined to be greater when the other portions of the formula for the CIC Period Bonus are known, such excess amount shall be paid in a lump sum cash payment within ten (10)&nbsp;days after such determination. The amount of the Bonus set forth in
the second sentence of Section&nbsp;3.4 shall be paid at the later of (i)&nbsp;in the next pay period after the Release becomes effective (not more than 75 days after your Date of Termination) or (ii)&nbsp;at the same time as such Bonus is paid to
other Company employees. Payments of vested equity awards under Section&nbsp;3.3 shall be made at such time as provided in the applicable award agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">4.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Special Rules for Termination Within 6 Months Before a Change in Control</U>. If you have a Qualifying
Termination within 6 months before a Change in Control, you shall initially receive the severance benefits for a Qualifying Termination during a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period as provided in Section&nbsp;2 and in accordance
with the time and form of payments set forth in Section&nbsp;4.1. Upon the occurrence of a Change in Control within the <FONT STYLE="white-space:nowrap">6-month</FONT> period following the Qualifying Termination, the amount of your severance
benefits for a Qualifying Termination during a CIC Period under Section&nbsp;3 shall be calculated and reduced by any payments received under Section&nbsp;2 and Section&nbsp;4.1 prior to the Change in Control. Such additional severance benefits
under Section&nbsp;3 shall be paid in such time and form as specified in Section&nbsp;4.2.1, provided that (i)&nbsp;for a payment otherwise due within 75 days after your Date of Termination, payment shall be made by the later of such date or the
date that is 30 days after the Change in Control, and (ii)&nbsp;payments under Section&nbsp;2.1 shall continue to be paid in installment payments in accordance with the time and form specified under Section&nbsp;4.1 to the extent determined
necessary to comply with Section&nbsp;409A of the Code. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Conditions</U>. As a condition precedent to your entitlement to benefits under Sections 2 and 3, you
agree to each of the following: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">You shall have executed, within 21 days, or if required for an effective release, 45 days, following your
Date of Termination, the Release, and the applicable revocation period set forth in the Release shall have expired. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">You agree to execute a resignation letter stating that, effective as of your Date of Termination, or such
earlier date as required or requested by the Company, you resign from all positions with the Company, whether as an employee, an officer, a director or otherwise. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">You shall reaffirm your agreement to abide by the covenants set forth in Section&nbsp;7.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>No Duty to Mitigate; <FONT STYLE="white-space:nowrap">Non-duplication</FONT></U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">6.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">You shall not be required to mitigate the amount of any payment or benefit provided for under this
<U>Exhibit C</U> by seeking other employment or otherwise, and no such payment or benefit shall be offset or reduced by the amount of any compensation or benefits provided to you in any subsequent employment. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">6.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Company does not intend to duplicate severance benefits. Accordingly, the severance payments and
benefits under this <U>Exhibit C</U> shall be reduced by any severance benefits to which you would otherwise be entitled pursuant to an agreement with the Company or any other general severance policy or plan maintained by the Company that provides
for severance benefits (unless the agreement, policy or plan expressly provides for severance benefits to be in addition to those provided under this <U>Exhibit C</U>). The severance payments and benefits to which you are otherwise entitled shall be
further reduced (but not below zero) by any payments or benefits to which you may be entitled under any federal, state or local plant-closing (or similar or analogous) laws or mandatory severance benefits under the laws of any other applicable
jurisdiction. Any such reductions or offsets in severance benefits shall be made in a manner that complies with Code Section&nbsp;409A (if applicable). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Restrictive Covenants</U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">7.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Confidential Information</U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">7.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Nondisclosure and <FONT STYLE="white-space:nowrap">Non-Use</FONT></U>. Both during the term of your
employment with Company and thereafter, you covenant and agree that you (i)&nbsp;shall exercise the utmost diligence to protect and safeguard the Confidential Information of the Company; (ii)&nbsp;shall not disclose to any third party any
Confidential Information, except as may be required by the Company in the course of your employment or by law; and (iii)&nbsp;shall not use Confidential Information except for the benefit of the Company. You acknowledge that Confidential Information
has been and will be developed and acquired by the Company by means of substantial expense and effort, that the Confidential Information is a valuable proprietary asset of the Company&#146;s business, and that its disclosure would cause substantial
and irreparable injury to the Company&#146;s business. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">7.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Definition of Confidential Information</U>. &#147;Confidential Information&#148; means all information of
a confidential or proprietary nature, whether or not specifically labeled or identified as &#147;confidential,&#148; in any form or medium, that is or was disclosed to, or developed or learned by, you in connection with your past, present or future
employment with the Company and that relates to the business, products, services, research or development of any of the Company or its suppliers, distributors or customers. Confidential Information includes, but is not limited to, the following:
(i)&nbsp;internal business information (including, but not limited to, information relating to strategic plans and practices, business, training, marketing, promotional and sales plans and practices, cost, rate and pricing structures, accounting and
business methods); (ii) identities of, individual </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="20%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
requirements of, specific contractual arrangements with, and information about, any of the Company&#146;s suppliers, distributors and customers and their confidential information;
(iii)&nbsp;trade secrets, <FONT STYLE="white-space:nowrap">know-how,</FONT> compilations of data and analyses, techniques, systems, formulae, research, records, reports, manuals, documentation, models, data and data bases relating thereto;
(iv)&nbsp;inventions, innovations, improvements, developments, methods, designs, analyses, drawings, reports and all similar or related information (whether or not patentable); and (v)&nbsp;other information or thing that has economic value, actual
or potential, from not being generally known to or not being readily ascertainable by proper means by other persons. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">7.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Not Confidential Information</U>. Confidential Information shall not include information that you can
demonstrate: (i)&nbsp;is publicly known through no wrongful act or breach of obligation of confidentiality by you; (ii)&nbsp;was rightfully received by you from a third party without a breach of any obligation of confidentiality by such third party;
or (iii)&nbsp;was known to you on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis prior to your employment with the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">7.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Presumption of Confidentiality</U>. In any judicial proceeding, it will be presumed that the Confidential
Information constitutes protectable trade secrets, and you will bear the burden of proving that any Confidential Information is publicly or rightfully known by you. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">7.1.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Return of Confidential Information and Materials</U>. You agree to return to the Company either before or
immediately upon the termination of your employment with the Company any and all information, materials or equipment which constitutes, contains or in any way relates to the Confidential Information and any other document, equipment or materials of
any kind relating in any way to the business of the Company in your possession, custody or control, which was obtained by you during the course of or as a result of your employment with the Company, whether confidential or not, including, but
without limitation, any copies thereof which may have been made by or for you. You shall also provide the Company, if requested to do so, the name of your new employer, and the Company shall have the right to advise any subsequent employer of your
obligations hereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">7.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Inventions</U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">7.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Ownership of Inventions</U>. Any and all Inventions created or developed by you alone or with others
during the term of your employment, whether or not during working hours and whether on the Company&#146;s premises or elsewhere, shall be deemed works for hire and will be the sole and exclusive property of the Company if the Invention is:
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) within the scope of your duties assigned or implied in accordance with your position; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) a product, service, or other item which would be in competition with
Company Products or which is related to Company Products, whether presently existing, under development, or under active consideration; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) in whole or in part, the result of your use of the Company&#146;s resources, including, without limitation, personnel,
computers, equipment, facilities or otherwise. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">7.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Assignment of Inventions</U>. You shall promptly and fully disclose all Inventions to the Company and
shall cooperate and perform all actions reasonably requested by the Company to establish, confirm and protect the Company&#146;s right, title and interest in each such Invention. During the term of your employment with the Company and after
termination of such employment, if the Company should then so request, you agree to assign and do hereby assign to the Company all rights in the Inventions. You agree to execute and deliver to the Company any instruments the Company deems necessary
to vest in the Company all title to and rights in the Inventions which you are legally authorized to grant. You agree to execute and deliver to the Company all proper papers for use in applying for, obtaining, maintaining, amending and enforcing any
legal protections that the Company may desire. You further agree to assist fully the Company or its nominees in the preparation and prosecution of any litigation connected with the Inventions. If the Company is unable because of your mental or
physical incapacity or for any other reason (including, but without limitation, your refusal to do so after request therefor is made by the Company) to secure your signature to apply for or to pursue any application for any United States or foreign
patents or copyright registrations covering Inventions belonging to or assigned to the Company pursuant to this Agreement, then you hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as your agent and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> to act for and on your behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and
issuance of patents or copyright registrations thereon with the same legal force and effect as if executed by you. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">7.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> of Employees</U>. During the <FONT
STYLE="white-space:nowrap">18-month</FONT> period immediately following your Date of Termination, you shall not, directly or indirectly, induce, solicit or encourage any employee of the Company to terminate or alter his or her relationship with the
Company. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Code Sections 280G and 4999</U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">8.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Adjustments to Payments</U>. Anything in this Agreement to the contrary notwithstanding, if (a)&nbsp;it
is determined that any payment or distribution by the Company to you or for your benefit (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise) (the &#147;Payments&#148;) would be subject to
the excise tax imposed by Section&nbsp;4999 (or any successor provisions) of the Code, or (b)&nbsp;any interest or penalty is incurred by you with respect to such excise tax (such excise tax, together with any such interest and penalties, is
hereinafter collectively referred to as the &#147;Excise Tax&#148;), then the Payments shall be reduced (but not below zero) if and to the extent that such reduction would result in you retaining a larger amount, on an
<FONT STYLE="white-space:nowrap">after-tax</FONT> basis (taking into account federal, state and local income taxes and the imposition of the Excise Tax), than if you received all of the Payments. The Company shall reduce or eliminate the Payments
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
by first reducing or eliminating the portion of the Payments which are not payable in cash and then by reducing or eliminating cash payments, in each case in reverse order beginning with payments
or benefits which are to be paid the farthest in time from the determination. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">8.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Determinations</U>. All determinations required to be made under this Section&nbsp;8, including whether
and when an adjustment to any Payments is required and, if applicable, which Payments are to be so adjusted, shall be made by an independent accounting firm selected by the Company from among the four largest accounting firms in the United States or
any nationally recognized financial planning and benefits consulting company (the &#147;Accounting Firm&#148;) which shall provide detailed supporting calculations both to the Company and you at such time as may be requested by the Company, or
earlier within 15 business days of the receipt of notice from you that there has been a Payment. If the Accounting Firm that the Company selects is serving as accountant or auditor for the individual, entity or group effecting the Change in Control,
the Company shall appoint another nationally recognized accounting firm to make the determinations required hereunder (which accounting firm shall then be referred to as the Accounting Firm hereunder). All fees and expenses of the Accounting Firm
shall be borne solely by the Company. If the Accounting Firm determines that no Excise Tax is payable by you, it shall furnish you with a written opinion that failure to report the Excise Tax on your applicable federal income tax return would not
result in the imposition of a negligence or similar penalty. Any determination by the Accounting Firm shall be binding upon the Company and you. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Miscellaneous</U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">9.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Successors&#146; Binding Obligation</U>. The provisions of this <U>Exhibit C</U> will be binding upon any
successor to the Company, its assets, its businesses or its interest (whether as a result of the occurrence of a Change in Control or otherwise), in the same manner and to the same extent that the Company would be obligated under this <U>Exhibit
C</U> if no succession had taken place. In the case of any transaction in which a successor would not by the foregoing provision or by operation of law be bound by this <U>Exhibit C</U>, the Company shall require any successor to expressly and
unconditionally assume this <U>Exhibit C</U> in writing and honor the obligations of the Company hereunder, in the same manner and to the same extent that the Company would be required to perform if no succession had taken place. All payments and
benefits that become due to you under this <U>Exhibit C</U> will inure to the benefit of your heirs, assigns, designees or legal representatives. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">9.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>No Assignment or Transfer; Beneficiaries; Unfunded Obligations</U>. Except as otherwise determined by the
Board, benefits payable under this <U>Exhibit C</U> shall not be assignable or transferable by you, and shall not be subject in any manner to assignment, alienation, pledge, encumbrance or charge. Notwithstanding the foregoing, in the event of your
death, except as otherwise provided by the Board, benefits earned but unpaid under this <U>Exhibit C</U> shall become payable to your beneficiary as designated by you in the manner prescribed by the Company or, in the absence of an authorized
beneficiary designation, by a legatee or legatees of your benefit under this <U>Exhibit C</U> in accordance with your last will or by your executors, personal representatives or distributees of such benefits under this <U>Exhibit C</U> in accordance
with your will or the laws of descent and distribution. The amounts to be paid to you under this <U>Exhibit C</U> are unfunded obligations of the Company. The Company is not required to segregate any monies or other assets from its general
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
funds with respect to these obligations. You shall not have any preference or security interest in any assets of the Company other than as a general unsecured creditor. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">9.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Attorney Fees for Enforcement in Connection with CIC Period Termination</U>. If your Date of Termination
occurs within the CIC Period, the Company shall pay on your behalf or reimburse to you promptly (in no event later than 30 days after the invoice date) all reasonable costs and expenses (including fees and disbursements of counsel) incurred by you
in seeking to enforce rights pursuant to this <U>Exhibit C</U>, whether or not you are successful in asserting such rights; provided, however, that no reimbursement shall be made of such expenses relating to any unsuccessful assertion of rights if
and to the extent that your assertion of such rights was in bad faith. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><U>Definitions</U>. As used in this Agreement, the following terms have the meanings set forth below:
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Agreement</I>&#148; means this offer letter, as it may be amended pursuant to its terms,
between James R. Anderson and the Company, dated as of the date that appears on the first page of such Agreement, and including all exhibits thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Accrued Obligations</I>&#148; means vested amounts payable to you upon any termination of employment with the Company,
including (i)&nbsp;your earned but unpaid Base Salary from the Company through the Date of Termination, (ii)&nbsp;any outstanding Bonus for which payment is due and owing as of the Date of Termination, (iii)&nbsp;any vested employee benefits as
determined under the applicable plan, and (iv)&nbsp;any unreimbursed expenses properly incurred and reported by you in accordance with the Company&#146;s business expense reimbursement policy. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Base Salary</I>&#148; means your annual salary for all services rendered as in effect at the time a benefit under this
<U>Exhibit C</U> is calculated; provided, however, that in case of a Qualifying Termination as the result of Good Reason triggered by a reduction in Base Salary, &#147;Base Salary&#148; shall mean your annual salary as in effect immediately before
the event giving rise to Good Reason. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Bonus</I>,&#148; at the time that a benefit under this <U>Exhibit C</U> is
calculated, means the bonus(es) payable to you pursuant to the Company&#146;s BIP, GRIP or other incentive bonus plan that is in effect at such time. For this purpose, the &#147;BIP&#148; means the Company&#146;s Bonus Incentive Program and the
&#147;GRIP&#148; means the Company&#146;s Goals/Results Incentive Program, in each case as such program may be amended from time to time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Cause</I>&#148; shall mean (i)&nbsp;your material breach of this Agreement that is not corrected within a 30 day
correction period that begins upon delivery to you of a written demand from the Company that describes the basis for the Company&#146;s belief you have materially breached this Agreement; (ii)&nbsp;any refusal to comply with the reasonable and
lawful instructions of the Board; (iii)&nbsp;any willful act of fraud or dishonesty that causes material damage to the Company; (iv)&nbsp;any willful violation of the Company&#146;s insider trading policy; (v)&nbsp;any willful violation of the
Company&#146;s conflict of interest policies; (vi)&nbsp;any willful unauthorized use or disclosure of trade secrets or other confidential information; or (vii)&nbsp;your conviction of a felony. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Change in Control</I>&#148; means a &#147;Change in Control&#148; as defined under the Coherent Corp. Omnibus
Incentive Plan (or any successor plan thereto). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>CIC Period</I>&#148; means the period commencing on the date six
months prior to a Change in Control and ending on the date that is the last day of the 18<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> month following the Change in Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>CIC Period Bonus</I>&#148; means, the greater of (i)&nbsp;Bonus at
target (A)&nbsp;for the performance period in which the Change in Control occurs (or for the immediately preceding performance period if the target payment with respect to you for the performance period in which the Change in Control occurs has not
yet been established) (without regard to any reduction made in the target payment within the six month period prior to the Change in Control) or (B)&nbsp;for the performance period in which your Date of Termination occurs, whichever target payment
is highest and (ii)&nbsp;Bonus based on performance (A)&nbsp;for the performance period in which the Change in Control occurs (but not less than that projected as of the Change in Control if the performance period has not been completed as of the
Change in Control), or (B)&nbsp;for the performance period in which your Date of Termination occurs, whichever performance payment is highest. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Company</I>&#148; means Coherent Corp., provided that for purposes of Section&nbsp;7 of this <U>Exhibit C</U>,
&#147;Company&#148; means collectively, Coherent Corp. and any other individual or entity who, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with, Coherent Corp. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Company Products</I>&#148; means any products or services (i)&nbsp;designed, manufactured, purchased, distributed,
sold, assembled, provided and/or marketed by the Company, or (ii)&nbsp;that the Company has planned to design, manufacture, purchase, distribute, sell, assemble, provide or market, and for which you have provided services, or over which you had
direct or indirect managerial or supervisory authority, or about which you received Confidential Information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Date of Termination</I>&#148; means the date on which your employment with the Company terminates. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Disability</I>&#148; means your physical or mental illness, injury or infirmity which is reasonably likely to prevent
and/or prevents you from performing your essential job functions for a period of (A) 90 consecutive calendar days or (B)&nbsp;an aggregate of 120 calendar days out of any consecutive <FONT STYLE="white-space:nowrap">12-month</FONT> period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Good Reason</I>&#148; shall mean the occurrence of any of the following, without your express written consent:
(i)&nbsp;a material diminution of your duties, responsibilities, or authority; (ii)&nbsp;a material diminution of your Base Salary or Target Bonus Amount; (iii)&nbsp;the Company&#146;s material breach of this Agreement; (iv)&nbsp;a requirement
imposed by the Company or any successor to the Company that you report to a corporate officer or employee rather than to the Board or any successor Board; (v)&nbsp;the Company requiring you to relocate your primary place of employment to a facility
or location that is more than 30 miles from your principal place of employment as of the Start Date; or (vi)&nbsp;the Company&#146;s failure to have any successor promptly agree in writing to assume the Company&#146;s obligations hereunder, except
where this Agreement is assumed by the successor by operation of law; provided, however, that you will only have Good Reason if (i)&nbsp;you notify the Board in writing of the existence of the condition which you believe constitutes Good Reason
within ninety (90)&nbsp;days of the initial existence of such condition (which notice specifically identifies such condition), (ii) the Company fails to remedy such condition within thirty (30)&nbsp;days after the date on which the Board receives
such notice (the &#147;Remedial Period&#148;), and (iii)&nbsp;your resignation is effective within thirty (30)&nbsp;days after the expiration of the Remedial Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Healthcare Coverage</I>&#148; means coverage for you and your <FONT STYLE="white-space:nowrap">tax-qualified</FONT>
dependents under the Company&#146;s group health plan that provides medical care (including group dental and vision), based on the applicable plans and your coverage elections in effect immediately prior to your Date of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Termination. The Company&#146;s group health plan does not include other benefits offered under a Company welfare plan such as life insurance and disability insurance. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Inventions</I>&#148; means any and all developments, discoveries, inventions, enhancements, modifications and
improvements by you to any Company Product. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I><FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period</I>&#148;
means the period prior to or following a CIC Period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Qualifying Termination</I>&#148; means a
(i)&nbsp;termination of your employment with the Company by the Company other than for Cause, death or Disability, or (ii)&nbsp;termination of your employment with the Company as a result of a resignation by you for Good Reason. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Release</I>&#148; means the waiver and release of claims substantially in the form attached hereto as Annex 1. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<I>Target Bonus Amount</I>&#148; means, with respect to any fiscal year of the Company, the amount of the target Bonus
for such fiscal year (including under both the BIP and the GRIP, if applicable). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Annex 1: Form of Release </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>GENERAL RELEASE AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This General Release Agreement (this &#147;Agreement&#148;) is made and entered into by <B>James R. Anderson</B>
(&#147;Executive&#148; or &#147;Your&#148; or &#147;Your&#148;) (collectively, referred to in this Agreement as &#147;<B>Executive</B>&#148;) and <B>Coherent Corp.</B>, any parent, subsidiary, affiliate, successor, predecessor or otherwise related
companies, and the past, present, and future employees, agents, officers, attorneys, directors, shareholders, members, managers and executive benefit programs of any of them, and their agents and insurers (collectively, referred to in this Agreement
as the &#147;<B>Company</B>&#148;). This Agreement shall become effective upon the signing of this Agreement by You or, if applicable, as defined in Section&nbsp;9.2 below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In consideration of the severance pay and benefits provided to Executive as set forth in the offer letter agreement between
Executive and the Company dated May&nbsp;31, 2024 (the &#147;<B>Offer Letter</B>&#148;), as well as any promises set forth in this Agreement, Executive agrees as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B></B>1.0<B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Release of Claims. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1.1 In exchange for the Company providing You with the payments and other benefits set forth in Exhibit C of the Offer Letter
(the &#147;<B>Severance Benefits</B>&#148;), You, and Your spouse, attorneys, heirs, dependents, beneficiaries, executors, administrators, successors, and assigns, hereby unconditionally release and completely and forever discharge the Company, on
behalf of and for the benefit of itself, all related corporate entities and partnerships, and each of their past, present and future employees, officers, directors, attorneys, owners, partners, members, insurers, benefit plan fiduciaries and agents,
and all of their respective successors and assigns (&#147;<I><U>Released Parties</U></I>&#148;), from any and all rights, claims, causes of action, or lawsuits whether known or unknown, that you ever had, now have, or may have against any or all of
the Released Parties up to the date of execution of this Agreement including, without limitation, any and all claims you had, have, or may have arising out of or relating to your employment with the Company or the separation of that employment, for
any and all reasons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You specifically release Released Parties from any rights or claims that you may have based upon the
Employee Retirement Income Security Act, Title VII of the Civil Rights Act of 1964, the Americans With Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Equal Pay Act, the Family and Medical Leave Act, Sections 1981
through 1988 of U.S.C. Title 42, all as amended, and any rules or regulations under such laws and authorities; all Pennsylvania employment discrimination laws, including but not limited to the Pennsylvania Human Relations Act; the Pennsylvania Equal
Pay Act; the Pennsylvania Minimum Wage Act; the Pennsylvania Wage Payment and Collection Law; Pennsylvania statutes regarding whistleblower protection, personnel Files, criminal records, wage complaints, retaliation; all as amended together with all
of their respective implementing regulations; and/or any other federal, state or local laws or regulations prohibiting employment discrimination or which otherwise regulate employment terms and conditions. You also release the Released Parties from
any claim for negligence, wrongful discharge, unfair treatment, defamation, breach of public policy, express or implied contract, or any other claims arising under common law that relate in any way to your employment with the Company or the
termination thereof. The foregoing description of claims is intended to be illustrative and is not exhaustive. The Parties intend this release to be a release of any and all claims to the fullest extent permissible under law. This waiver and release
is of Your rights to all remedies and damages available to You in law or equity, including but not limited </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
to Your right to compensation, backpay, front pay, <FONT STYLE="white-space:nowrap">non-economic</FONT> damages, punitive and exemplary damages, statutory damages, attorneys&#146; fees,
injunctive relief and declaratory judgments. This general release does not extend to claims which You do not know or suspect exist at the time of executing the release, which if known by You would have materially affected Your entering into this
Agreement with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1.2 Notwithstanding the release contained in Section&nbsp;1.1, You do not waive (i)&nbsp;Your
entitlement to receive any 401(k), pension plan benefits, or Company ERISA-covered benefits that shall have vested (if any) as of the date You sign this Agreement to the extent You have any entitlement to those benefits under the terms of the
relevant plans, or (ii)&nbsp;Your right to file a charge with the EEOC or participate in an investigation conducted by the EEOC; however, You expressly waive Your right to monetary or other relief should any administrative agency, including but not
limited to the EEOC, pursue any claim on Your behalf. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1.3 The release contained in Section&nbsp;1.1 above does not apply
to any claim or rights that may arise after that date You sign this Agreement or claims that the controlling law clearly states may not be released by private agreement. You also understand that You are not waiving Your rights to unemployment
compensation. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B></B>2.0<B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Covenant Not to Sue. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2.1 You warrant that You do not have any complaint, charge or grievance against any Released Party pending before any federal,
state or local court or administrative or arbitral agency, and You further covenant not to sue, file a lawsuit, or commence any other proceeding, arbitral, administrative or judicial action, against any of the Released Parties in any court of law or
equity, or before any arbitral body or administrative agency, with respect to any matter released in Section&nbsp;1.1 above; provided, however, that this covenant not to sue does not affect Your rights to enforce appropriately the terms of the Offer
Letter in a court of competent jurisdiction and does not affect Your right to file a charge with the EEOC or participate in an investigation conducted by the EEOC; however, You expressly waive Your right to monetary or other relief should any
administrative agency, including but not limited to the EEOC, pursue any claim on Your behalf. Notwithstanding the foregoing, nothing herein shall limit Your right to receive an award for information provided to the Securities and Exchange
Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Nothing in this Agreement prohibits You from reporting possible violations of federal law or regulation to
any governmental agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or making other disclosures that are protected under the whistleblower
provisions of federal law or regulation. You do not need the prior authorization of the Company to make any such reports or disclosures and You are not required to notify the Company that You have made such reports or disclosures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2.2 Should You file a lawsuit with any court concerning any claim, demand, issue, or cause of action waived, released or
discharged through this Agreement or otherwise in breach of Section&nbsp;2.1 above, You agree (i)&nbsp;that any amounts payable or paid to You, as applicable, pursuant to Exhibit C of the Offer Letter shall no longer be payable and, if already paid,
shall promptly be returned to the Company and (ii)&nbsp;to the fullest extent allowed by applicable law, to indemnify the Released Parties for all costs and expenses incurred by them in defending such lawsuit. You further agree that nothing in this
Agreement shall limit the right of a court to determine, in its sole discretion, that the Released Parties are entitled to restitution, recoupment or set off of any monies paid should the release of any claims under this Agreement subsequently be
found to be invalid. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2.3 You agree not to advocate or incite the institution of, or assist or
participate in, any suit, unrest, complaint, charge or administrative proceeding by any other person against any of the Released Parties, unless compelled by legal process to do so. Nothing in this Section&nbsp;2 shall prohibit any Party from
lawfully participating or cooperating in an investigative proceeding of any federal, state or local government agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3.0 <B><FONT
STYLE="white-space:nowrap">Non-Admission</FONT> of Liability</B>. You agree that this Agreement shall not in any way be construed as an admission that any of the Released Parties owe You any money or have acted wrongfully, unlawfully, or unfairly in
any way towards You. In fact, You understand that the Released Parties specifically deny that they have violated any federal, state or local law or ordinance or any right or obligation that they owe or might have owed to You at any time, and
maintain that they have at all times treated You in a fair, <FONT STYLE="white-space:nowrap">non-discriminatory</FONT> and <FONT STYLE="white-space:nowrap">non-retaliatory</FONT> manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">4.0 <B>Confidentiality of Agreement</B>. You also acknowledge and agree that You shall not publicize, communicate, authorize or permit the
publication or communication in any form whatsoever of the contents of this Agreement or the events giving rise thereto, except to Your immediate family, Your financial advisors and/or legal counsel, or where required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">5.0 <B>Representations and Indemnification</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">5.1 You represent to the company that You will abide by any and all post-employment restrictive covenants You signed or
entered into in connection with Your employment, including but not limited to, covenants relating to competition, solicitation or hiring of employees, solicitation of customers, and confidentiality. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">5.2 You agree that You will indemnify and hold the Released Parties harmless from any loss, cost, damage or expense (including
attorneys&#146; fees) incurred by the Released Parties arising out of Your breach of any portion of this Agreement or any post-employment restrictive covenant You signed or entered into in connection with Your employment. You also agree and
understand that Your entitlement to and retention of the Severance Benefits the Company has agreed to provide to You are expressly conditioned upon Your fulfillment of Your promises herein and any applicable post-employment restrictive covenants,
and You agree that if You breach this Agreement or any applicable post-employment restrictive covenants that any amounts payable or paid to You, as applicable, pursuant to the Exhibit C of the Offer Letter, shall no longer be payable and, if already
paid, shall promptly be returned to the Company within seven days of the Company providing you with written notice of Your breach of any provision of this Agreement or any applicable post-employment restrictive covenants, to the extent permitted or
required by law. The Company shall determine whether a breach has occurred in its sole discretion and under any applicable law or regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6.0 <B>Miscellaneous</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6.1 <I>Governing Law and Venue</I>. This Agreement and all things relating or pertaining to it shall be governed by, and
construed in accordance with, the laws of the Commonwealth of Pennsylvania, without reference to conflict of laws principles. Any action relating to this Agreement must be instituted in the courts of Butler County, Pennsylvania, or the federal
courts of the Western District of Pennsylvania. The Company and Employee hereby consent to the jurisdiction of such courts and waive any right or defense relating to venue or jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6.2 <I>Severability</I>. Whenever possible, each provision of this Agreement shall be interpreted so as to be effective and
valid under applicable law, but if any of its provisions is prohibited by or invalid </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
under such law, such provision shall be ineffective to the extent of such prohibition or invalidity, and severed from this Agreement without invalidating any other part of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6.3 <I>Proper Construction</I>. The language of this Agreement shall be construed within the context of the whole Agreement
and according to its fair meaning, and not strictly for or against either the Parties. The section headings used in this Agreement are intended solely for convenience of reference and shall not in any manner amplify, limit, modify or otherwise be
used in its interpretation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6.4 <I>Survival</I>. You acknowledge that the covenants in the Offer Letter, and any
provisions contained in the Offer Letter that are intended to survive following termination of Your employment, shall survive the execution of this Agreement by You. You further acknowledge that any and all post-employment restrictive covenants You
signed in connection with Your employment, including covenants relating to solicitation or hiring, remain in full force and effect, and a breach of those covenants or agreements will also constitute a breach of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6.5 <I>Amendments</I>. This Agreement may be modified, altered or terminated only by an express written agreement between You
and the Company, that is signed by both parties, and to which a copy of this Agreement is attached. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6.6
<I>Counterparts</I>. This Agreement may be signed in counterparts, which together shall be treated as one document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">7.0
<B>Acknowledgment</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">7.1 You confirm that, to the best of Your knowledge, You have returned to the Company all of its
property, including without limitation, computer equipment, software, keys and access cards, credit cards, files and any documents (including computerized data and any copies made of computerized data or software) containing information concerning
the Company, its business or its business relationships. You also commit to deleting and finally purging any duplicates of files or documents that contain the Company information from any computer or other device that remains Your property after the
Termination Date, provided such information is not subject to an ongoing litigation hold. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">7.2 You acknowledge that, if
you are age 40 or over, You have had 21 days, or if required for an effective release, 45 days, after receipt of this Agreement (and Appendix A if required to be attached hereto) to consider whether to execute it, and you understand all the
provisions of this agreement. You also understand that, after you execute this Agreement, you have seven days to revoke the portion of this Agreement that relates to waiver and release of any claim you might assert under the Age Discrimination in
Employment Act (&#147;ADEA&#148;). The parties agree that no payment set forth in Exhibit C of the Offer Letter will be made until after the seven day revocation period has expired (the eighth day after You execute this Agreement being the
&#147;Effective Date&#148; of this Agreement for those age 40 or over). You understand that, by signing this Agreement, You are not waiving or releasing any ADEA claims based on actions or omissions that occur after the date You sign. You agree that
any revocation of Your ADEA waiver and release must be made in writing and postmarked on or before the seventh day following the execution of this Agreement and sent by certified mail to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">5000 Ericsson Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Warrendale, PA 15806 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Attention: Chief Legal Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Email: Legal.Notices@coherent.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">or to such other address as the Company may have furnished to You in writing
in accordance herewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">7.3 With the exception of the Severance Benefits, and of your final paycheck (to include Your
regular wages and any accrued but unused vacation or other paid time off to be delivered by the next regularly scheduled payday or otherwise as required by law), You acknowledge payment of all compensation due to You by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">7.4 You acknowledge that You have been advised in writing, and hereby are advised, to seek legal counsel concerning the terms
of this Agreement. You warrant that you have read this Agreement, are knowingly and voluntarily entering into it and intend to be legally bound by it, and that your agreement to it is not the result of coercion or duress by the Company. You certify
and agree that you are authorized and competent to sign this Agreement, and that you are receiving valuable and adequate consideration under it. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BY
SIGNING BELOW, YOU ACKNOWLEDGE THAT (1)&nbsp;YOU HAVE CAREFULLY READ AND CONSIDERED THIS AGREEMENT; (2)&nbsp;HAVE BEEN GIVEN SUFFICIENT TIME TO CONSIDER WHETHER TO SIGN IT; (3)&nbsp;RECOGNIZE AND UNDERSTAND THAT IT CONTAINS A FULL AND FINAL RELEASE
BY YOU OF ALL CLAIMS OF EVERY KIND AGAINST THE COMPANY ARISING UP TO THE TIME YOU SIGN IT, WHETHER YOU CURRENTLY KNOW OR SUSPECT THOSE CLAIMS TO EXIST; AND (4)&nbsp;KNOWINGLY AND VOLUNTARILY CONSENT TO THE TERMS OF THIS AGREEMENT WITH FULL
UNDERSTANDING OF THEIR MEANING. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">IN WITNESS WHEREOF, Executive has executed this General Release Agreement as of the
date set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EXECUTIVE</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">James R.
Anderson</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Date: _________________</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Received, Acknowledged and Accepted:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>COHERENT CORP.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By: ___________________</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">[Name, Title]</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Date: __________________</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d845190dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COHERENT CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDUCEMENT AWARD AGREEMENT (RESTRICTED SHARE UNITS) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">THIS INDUCEMENT AWARD AGREEMENT (RESTRICTED SHARE UNITS) (this <I>&#147;Agreement&#148;) </I>is dated as of June&nbsp;3, 2024
(the &#147;<I>Grant Date</I>&#148;), by and between Coherent Corp., a Pennsylvania corporation <I>(&#147;Coherent&#148;)</I>, and JAMES R. ANDERSON, the newly hired Chief Executive Officer of Coherent (the <I>&#147;Recipient&#148;),</I> all as
contemplated by the offer letter of employment by and between Coherent and Recipient dated May&nbsp;31, 2024 (the &#147;<I>Offer Letter</I>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Reference is made to the Employee Grant Details found on the Solium Shareworks system at https://Shareworks.Solium.com (or any
successor system selected by Coherent) (the <I>&#147;Solium Shareworks System&#148;</I>). Employee Grant Details for a specific Award can be found by clicking on such Award listed in the Stock Options and Awards section under the Portfolio tab (the
<I>&#147;Employee Grant Details&#148;</I>) of the Solium Shareworks System. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Award constitutes a <FONT
STYLE="white-space:nowrap">non-plan</FONT> &#147;employment inducement award&#148; as contemplated by New York Stock Exchange Listing Rule 303A.08 and is therefore not made pursuant to the Coherent Corp. Omnibus Incentive Plan as amended and
restated effective November&nbsp;9, 2023 (as may be amended and/or restated from time to time, the <I>&#147;Plan&#148;)</I>. Nonetheless, the terms and provisions of the Plan are hereby incorporated into this Agreement by this reference, as though
fully set forth herein, as if this Award was granted pursuant to the Plan. Capitalized terms used but not defined herein will have the same meaning as defined in the Plan. A copy of the Plan can be found on the Solium Shareworks System, and/or the
applicable Employee Grant Details. Reference further is made to the prospectus relating to the Plan, which also may be found on the Solium Shareworks System. This Agreement shall constitute an Award Agreement as that term is defined in the Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>NOW, THEREFORE, </B>for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,
and intending to be legally bound hereby, the Recipient and Coherent agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1. <U>Inducement Award &#150;
Restricted Share Units</U>. Coherent hereby grants to the Recipient an Award of Restricted Share Units, as specified in the Employee Grant Details. For the purposes of this Agreement, a &#147;Restricted Share Unit&#148; is the contingent right to
receive the equivalent of one (1)&nbsp;Share, in the event the Restricted Share Unit vests and becomes payable pursuant to the terms of this Agreement. Restricted Share Units shall be payable and settled solely in Coherent Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2. <U>Restrictions</U>. Except as otherwise provided in this Agreement, the Restricted Share Units shall vest and become
payable, subject to the terms of the Plan, as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Vesting Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">%&nbsp;Vesting</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First anniversary of Grant Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second anniversary of Grant Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third anniversary of Grant Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Only a whole number of Restricted Share Units shall become vested as of any given vesting date. If the number
of Restricted Share Units determined as of a vesting date is a fractional number, the number vesting shall be rounded down to the nearest whole number with any fractional portion carried forward. Restricted Share Units that have not vested may not
be sold, transferred, pledged, assigned or otherwise alienated or hypothecated. Restricted Share Units that have not vested shall be subject to forfeiture as provided in <U>Section</U><U></U><U>&nbsp;3</U>. Notwithstanding the foregoing, in the
event of the Recipient&#146;s Separation from Service upon normal retirement, as defined in Coherent&#146;s Global Retirement Policy, any unvested Restricted Share Units shall immediately vest and payment in respect thereof shall be made to the
Recipient no later than the seventy-fifth (75<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) calendar day following the date of Separation from Service. Upon the Recipient&#146;s Separation from Service due to death or permanent and total
disability, as defined in Code Section&nbsp;22(e)(3) (a <I>&#147;Disability&#148;</I>), any unvested Restricted Share Units shall immediately vest and payment in respect thereof shall be made to the Recipient no later than the seventy-fifth (75<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) calendar day following the date of Separation from Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3.
<U>Other Separation from Service</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) If the Recipient incurs a Separation from Service for any reason other than
those described in <U>Section</U><U></U><U>&nbsp;2</U> or <U>Section</U><U></U><U>&nbsp;4</U>, any Restricted Share Units which have not yet vested, as of the date of the Recipient&#146;s Separation from Service, shall be immediately forfeited by
the Recipient and the Recipient shall not be entitled to any compensation for lost vesting; provided, however, the Committee may determine that all or a portion of the Recipient&#146;s Restricted Share Units shall vest and be issued if the Recipient
incurs a Separation from Service under such special circumstances as the Committee deems appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) Notwithstanding
<U>Sections 2</U> and <U>3(a)</U> hereof, in the event of the Recipient&#146;s &#147;Qualifying Termination&#148; during a <FONT STYLE="white-space:nowrap">&#147;Non-CIC</FONT> Period&#148; (as those terms are defined in the Offer Letter), and
consistent with the requirements of Exhibit C to the Offer Letter, (i)&nbsp;any annual vesting tranche of the Restricted Share Units with a vesting date within twelve (12)&nbsp;months after the Recipient&#146;s &#147;Date of Termination&#148; (as
defined in the Offer Letter) will fully vest, (ii)&nbsp;any annual vesting tranche of the Restricted Share Units that began during the first twelve (12)&nbsp;months after the Recipient&#146;s Date of Termination shall vest pro rata based on a
fraction, the numerator of which is the number of months within such annual vesting tranche the Recipient would have been employed if the Recipient had remained employed through the first anniversary of the Recipient&#146;s Date of Termination, and
the denominator of which is twelve (12), and (iii)&nbsp;such earned and vested Restricted Shares Units shall be settled as soon as administratively practicable after the release described in the Offer Letter becomes effective (and in no event later
than seventy-five (75)&nbsp;days after the date of the Qualifying Termination). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">4. <U>Change in Control; Adjustments to Payments</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) <U>Change in Control</U>. Upon a Change in Control, the Award shall be treated in accordance with Section&nbsp;10 of the
Plan, or, if better, in accordance with Exhibit C to the Offer Letter for a Qualifying Termination during a &#147;CIC Period&#148; (as such term in the defined in the Offer Letter) with &#147;Cause&#148; and &#147;Good Reason&#148; for such purpose
as defined in the Offer Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) <U>Adjustments to Payments</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) Notwithstanding any provision to the contrary in this Agreement, if it is determined that any payment or distribution by
the Company to the Recipient or for the Recipient&#146;s benefit (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise) (the <I>&#147;Payments&#148;</I>) would be subject to the excise tax
imposed by Code Section&nbsp;4999, or any interest or penalty is incurred by the Recipient with respect to such excise tax (such excise tax, together with any such interest and penalties, collectively referred to as the <I>&#147;Excise
Tax&#148;</I>), then the Payments shall be reduced (but not below zero) if and to the extent that such reduction would result in the Recipient retaining a larger amount, on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis (taking into
account federal, state and local income taxes and the imposition of the Excise Tax), than if the Recipient received all of the Payments. The Payments shall be reduced or eliminated by first reducing or eliminating the portion of the Payments that
are not payable in cash and then by reducing or eliminating cash payments, in each case in reverse order beginning with payments or benefits that are to be paid the farthest in time from the determination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) All determinations required to be made under this <U>Section</U><U></U><U>&nbsp;4(d)</U>, including whether and when an
adjustment to any Payments is required and, if applicable, which Payments are to be so adjusted, shall be made by an independent accounting firm selected by Coherent from among the four (4)&nbsp;largest accounting firms in the United States or any
nationally-recognized financial planning and benefits consulting company (the <I>&#147;Accounting Firm&#148;</I>), which shall provide detailed supporting calculations both to Coherent and to the Recipient within fifteen (15)&nbsp;business days of
the receipt of notice from the Recipient that there has been a Payment, or such earlier time as is requested by Coherent. In the event that the Accounting Firm is serving as accountant or auditor for the individual, entity or group effecting the
Change in Control, Coherent shall appoint another nationally-recognized accounting firm to make the determinations required hereunder (which accounting firm shall then be referred to as the Accounting Firm hereunder). All fees and expenses of the
Accounting Firm shall be borne solely by Coherent. If the Accounting Firm determines that no Excise Tax is payable by the Recipient, it shall furnish the Recipient with a written opinion that failure to report the Excise Tax on the Recipient&#146;s
applicable federal income tax return would not result in the imposition of a negligence or similar penalty. Any determination by the Accounting Firm shall be binding upon the Company and the Recipient. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">5. <U>Delivery of Shares; Payment</U>. Except as otherwise provided in
<U>Section</U><U></U><U>&nbsp;2</U> or <U>Section</U><U></U><U>&nbsp;4</U>, Coherent shall cause a stock certificate (or equivalent electronic book entry) representing Shares equal to the number of Restricted Share Units vested and payable under
this Agreement to be issued to the Recipient on the applicable vesting date specified in the schedule in <U>Section</U><U></U><U>&nbsp;2</U> or on such other date as specified under this Agreement (or as soon as administratively practicable
thereafter, but in no event later than the seventy-fifth (75<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) calendar day following such applicable vesting date). Notwithstanding the foregoing, the Company, at its sole discretion, may settle
the Award in cash if necessary or appropriate for legal or administrative reasons based on laws in the Recipient&#146;s jurisdiction. If the Restricted Share Units are settled in cash, Coherent shall pay to the Recipient an amount in cash equal to
the product of (a)&nbsp;the number of Restricted Share Units vested and payable on the applicable vesting date specified in the schedule in <U>Section</U><U></U><U>&nbsp;2</U> and (b)&nbsp;the Fair Market Value on such applicable vesting date, with
such cash payment being made within the time period specified in this <U>Section</U><U></U><U>&nbsp;5</U>. In the event of the death of the Recipient, delivery of the applicable form of consideration set forth in this
<U>Section</U><U></U><U>&nbsp;5</U> shall be made to the Recipient&#146;s estate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6. <U>Limitation of Rights; Dividend
Equivalents</U>. The Recipient shall not have any rights of ownership of the Shares underlying the Restricted Share Units, including voting rights or the rights to receive dividends or other distributions, before the vesting of this Award. The
Recipient, however, shall be entitled to receive a cash payment equal to the cash dividends that would have been paid during the applicable vesting period (i.e., the period from the Grant Date through the applicable vesting date or earlier vesting
event pursuant to <U>Section</U><U></U><U>&nbsp;2</U> or <U>Section</U><U></U><U>&nbsp;4</U>) on the number of Shares underlying the Restricted Share Units then vesting if such Shares had been issued and outstanding during the applicable vesting
period. Such cash dividend equivalents will not vest or be paid prior to vesting of the Restricted Share Units to which they relate, as specified in this Agreement, and will be subject to cancellation and forfeiture to the same extent that the
related Restricted Share Units do not vest or are forfeited. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">7. <U>Nontransferability</U>. Except as otherwise provided
in the Plan, the Restricted Share Units shall not be sold, pledged, assigned, hypothecated, transferred or disposed of (a <I>&#147;Transfer&#148;) </I>in any manner, other than by will or the laws of descent and distribution. Any attempt to Transfer
the Restricted Share Units in violation of this Section or the Plan shall render this Award null and void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">8.
<U>Adjustments</U>. Upon any event described in Section&nbsp;12 of the Plan (entitled &#147;Adjustments&#148;) or any successor provision thereto, the terms of such Section&nbsp;12 of the Plan or any successor provision thereto shall apply to this
Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">9. <U>Fractional Shares</U>. Coherent shall not be required to issue any fractional Shares pursuant to this Award,
and notwithstanding <U>Section</U><U></U><U>&nbsp;2</U> of this Agreement, Coherent may round fractional Shares down to the nearest whole Share. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">10. <U>Responsibility for Taxes</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) Regardless of any action the Company takes with respect to any or all income tax, social insurance, payroll tax, fringe
benefit tax, payment on account or other <FONT STYLE="white-space:nowrap">tax-related</FONT> items related to the Recipient&#146;s participation in the Plan (<I><FONT STYLE="white-space:nowrap">&#147;Tax-Related</FONT> Items&#148;</I>), the
Recipient acknowledges that the ultimate liability for all <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items owed by the Recipient is and remains the Recipient&#146;s responsibility and that the Company (i)&nbsp;makes no representations or
undertakings regarding the treatment of any <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items in connection with any aspect of this Award, including the grant or vesting of this Award or the subsequent sale of Shares acquired pursuant to
this Award; and (ii)&nbsp;does not commit to structure the terms of the grant or any aspect of this Award to reduce or eliminate the Recipient&#146;s liability for <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items or achieve a particular tax
result. Further, if the Recipient is subject to <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items in more than one jurisdiction, the Recipient acknowledges and agrees that the Company may be required to withhold or account for <FONT
STYLE="white-space:nowrap">Tax-Related</FONT> Items in more than one jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) Prior to any relevant taxable or
tax withholding event, as applicable, the Recipient agrees to make adequate arrangements satisfactory to the Company to satisfy all <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items. In this regard, the Recipient authorizes the Company, or
their respective agents, at their discretion, to satisfy any applicable withholding obligations with regard to <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items by one or a combination of the following: (i)&nbsp;withholding from the
Recipient&#146;s wages or other cash compensation paid to the Recipient by the Company; (ii)&nbsp;withholding from the proceeds of the sale of Shares acquired upon vesting of this Award either through a voluntary sale or through a mandatory sale
arranged by the Company (on the Recipient&#146;s behalf pursuant to this authorization) without further consent; (iii)&nbsp;withholding Shares to be issued upon vesting of this Award; or (iv)&nbsp;any other method determined by the Committee and
permitted by applicable laws. Notwithstanding the foregoing, if the Recipient is subject to the short-swing profit rules of Section&nbsp;16(b) of the Exchange Act, the Company will withhold in Shares issuable at vesting of the Award upon the
relevant withholding event, unless otherwise determined by the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) The Company may withhold or account for <FONT
STYLE="white-space:nowrap">Tax-Related</FONT> Items by considering applicable withholding rates, including maximum applicable rates, in which case the Recipient may receive a refund of any over-withheld amount in cash (with no entitlement to the
equivalent in Shares) or, if not refunded, the Recipient may seek a refund from the local tax authorities. In the event of under-withholding, the Recipient may be required to pay any additional <FONT STYLE="white-space:nowrap">Tax-Related</FONT>
Items directly to the applicable tax authority or to the Company. If the obligation for <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items is satisfied by withholding in Shares, for tax purposes, the Recipient is deemed to have been issued
the full number of Shares, notwithstanding that a number of Shares is held back solely for the purpose of paying the <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) Finally, the Recipient shall pay to the Company any amount of <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items
that the Company may be required to withhold or account for as a result of the Recipient&#146;s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver Shares or the proceeds
from the sale of Shares if the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Recipient fails to comply with the Recipient&#146;s obligations in connection with the <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items as described in this
<U>Section</U><U></U><U>&nbsp;10</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">11. <U>Plan Provisions</U>. In the event of any conflict between the provisions of
this Agreement and the Plan, the Plan shall control, except that capitalized terms specifically defined in this Agreement shall have the meaning given to them in this Agreement with respect to their usage in this Agreement, notwithstanding the
definitions given to such terms in the Plan (which definitions shall control as they relate to the usage of such terms in the Plan). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">12. <U>No Continued Rights</U>. The granting of this Award shall not give the Recipient any rights to similar grants in future
years or any right to continuance of employment or other service with Coherent or its Subsidiaries, nor shall it interfere in any way with any right that the Company would otherwise have to terminate the Recipient&#146;s employment or other service
at any time, or the right of the Recipient to terminate his or her employment or other service at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">13. <U>Rights
Unsecured</U>. The Recipient shall have only Coherent&#146;s unfunded, unsecured promise to pay pursuant to the terms of this Agreement. The rights of the Recipient hereunder shall be that of a general unsecured creditor of Coherent and the
Recipient shall not have any security interest in any assets of Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">14. <U>Restrictive Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) While the Recipient is employed by the Company (including its Subsidiaries) and for a period of one (1)&nbsp;year after
the Recipient&#146;s Separation from Service for any reason (the &#147;<I>Restricted Period</I>&#148;), the Recipient will not directly or indirectly either alone or in association with others solicit, or permit any organization directly or
indirectly controlled by the Recipient to solicit, any employee or independent contractor of Coherent or its Subsidiaries to leave the employ or service of Coherent or its Subsidiaries. The Restricted Period will be tolled during and for any period
of time during which the Recipient is in violation of the restrictive covenants contained in this <U>Section</U><U></U><U>&nbsp;13(a)</U> and for any period of time which may be necessary to secure an order of court or injunction, either preliminary
or permanent, to enforce such covenants, such that the cumulative time period during which the Recipient is in compliance with the restrictive covenants contained in this <U>Section</U><U></U><U>&nbsp;13(a)</U> will not exceed the one (1)-year
period set forth above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) The Recipient acknowledges that certain materials, including information, data, technology
and other materials relating to customers, programs, costs, marketing, investment, sales activities, promotion, credit and financial data, manufacturing processes, financing methods, plans or the business and affairs of Coherent and its Subsidiaries
constitute proprietary confidential information and trade secrets. Accordingly, the Recipient will not at any time during or after the Recipient&#146;s employment with the Company or a Subsidiary disclose or use for the Recipient&#146;s own benefit
or purposes or the benefit or purposes of any other person, firm, partnership, joint venture, association, corporation or other business organization, entity or enterprise, other than the Company (including its Subsidiaries), any proprietary
confidential </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
information or trade secrets; provided that the foregoing shall not apply to information which is not unique to Coherent and its Subsidiaries or which is generally known to the industry or the
public other than as a result of the Recipient&#146;s breach of this covenant. The Recipient agrees that, upon the Recipient&#146;s Separation from Service for any reason, the Recipient will immediately return to Coherent all property of Coherent
and its Subsidiaries including all memoranda, books, technical and/or lab notebooks, customer product and pricing data, papers, plans, information, letters and other data, and all copies thereof or therefrom, which in any way relate to the business
of Coherent and its Subsidiaries, except that the Recipient may retain personal items. The Recipient further agrees that the Recipient will not retain or use for the Recipient&#146;s account at any time any trade names, trademark or other
proprietary business designation used or owned in connection with the business of Coherent and its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c)
Nothing herein is intended to or shall limit, prevent, impede or interfere with the Recipient&#146;s non-waivable right, without prior notice to the Company, to provide information to the government, participate in investigations, testify in
proceedings regarding the Company&#146;s past or future conduct, or engage in any activities protected under whistleblower statutes, or to receive and fully retain a monetary award from a government-administered whistleblower award program for
providing information directly to a government agency. Further, the Recipient understands that pursuant to the Defend Trade Secrets Act of 2016, the Recipient shall not be held criminally, or civilly, liable under any Federal or State trade secret
law for the disclosure of a trade secret that is made in confidence either directly or indirectly to a Federal, State, or local government official, or an attorney, for the sole purpose of reporting, or investigating, a violation of law. Moreover,
the Recipient understands that he or she may disclose trade secrets in a complaint, or other document, filed in a lawsuit, or other proceeding, if such filing is made under seal. Finally, the Recipient understands that if he or she files a lawsuit
alleging retaliation by the Company for reporting a suspected violation of the law, the Recipient may disclose the trade secret to the attorney and use the trade secret in the court proceeding, so long as any document containing the trade secret is
filed under seal and the Recipient does not disclose the trade secret except pursuant to court order. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">15. <U>Data
Collection and Usage</U>. Pursuant to applicable data protection laws, the Recipient is hereby notified that the Company collects, processes, uses and transfers certain personally-identifiable information about the Recipient for the exclusive
legitimate purpose of granting Restricted Share Units and implementing, administering and managing the Recipient&#146;s participation in the Plan. For California residents, the categories of personal, including sensitive personal information, are
identifiers, characteristics of protected classifications under California or federal law, professional or employment related information, social security, driver&#146;s license, state identification card, or passport number, and any personal
information that identifies, relates to, describes, or is capable of being associated with a particular individual. The personal information is not sold or shared for cross-context behavioral advertising. For additional information, please see
Exhibit E of the Global Employee Data Privacy Policy and Notice which can be found at: Policy <FONT STYLE="white-space:nowrap">Center&#151;PVY-001</FONT> Employee Privacy Policy and Notice&#151;All Documents (sharepoint.com). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">16. <U>Remedies; </U><U>Clawback</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) Coherent and the Recipient acknowledge and agree that that any violation by the Recipient of any of the restrictive
covenants contained in <U>Section</U><U></U><U>&nbsp;14</U> would cause immediate, material and irreparable harm to Coherent and its Subsidiaries which may not adequately be compensated by money damages and, therefore, Coherent and its Subsidiaries
shall be entitled to injunctive relief (including one (1)&nbsp;or more preliminary injunctions and/or ex parte restraining orders) in addition to, and not in derogation of, any other remedies provided by law, in equity or otherwise for such a
violation, including the right to have such covenants specifically enforced by any court of competent jurisdiction, the rights under <U>Section</U><U></U><U>&nbsp;14(b)</U>, and the right to require the Recipient to account for and pay over to
Coherent all benefits derived or received by the Recipient as a result of any such breach of covenant together with interest thereon, from the date of such initial violation until such sums are received by Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) In the event that the Recipient violates or breaches any of the covenants set forth in
<U>Section</U><U></U><U>&nbsp;14</U>, the Restricted Share Units (whether vested or unvested) and the right to receive Shares in exchange for such Restricted Share Units shall be forfeited. Coherent shall also have the right, in its sole discretion,
in addition to any other remedies or damages provided by law, in equity or otherwise, to demand and require the Recipient, (i)&nbsp;to the extent that any cash payment was received with respect to such Restricted Share Units, to return and transfer
to Coherent any such cash payment, (ii)&nbsp;to the extent that any Shares were received with respect to such Restricted Share Units, to return and transfer to Coherent any such shares directly or beneficially owned by the Recipient, and
(iii)&nbsp;to the extent that the Recipient sold or transferred any such Shares, to disgorge and/or repay to Coherent any profits or other economic value (as determined by Coherent) made or realized by the Recipient with respect to such Shares,
including the value of any gift thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) This Award, <B>and any amounts or benefits received or outstanding under the
Plan, as well as any other incentive awards previously granted to the Recipient by the Company</B>, shall be subject to potential clawback, cancellation, recoupment, rescission, payback, reduction, or other similar action in accordance with the
terms or conditions of any applicable Company clawback or similar policy or any applicable law related to such actions, as may be in effect from time to time, including the requirements of (a)&nbsp;Section&nbsp;304 of the Sarbanes Oxley Act and
Section&nbsp;954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act (including any rules implementing those statutory requirements adopted under the Exchange Act or by the applicable exchange on which Shares are listed), (b) similar
rules under the laws of any other jurisdiction, and (c)&nbsp;any policies adopted by the Company to implement such requirements. The Recipient acknowledges and consents to the Company&#146;s application, implementation and enforcement of any
applicable Company clawback or similar policy that may apply to the Recipient, whether adopted prior to or following the Grant Date, and any provision of applicable law relating to clawback, cancellation, recoupment, rescission, payback, or
reduction of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
compensation, and agrees that the Company may take such actions as may be necessary to effectuate any such policy or applicable law, without further consideration or action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">17. <U>Recipient Acknowledgments</U>. The Recipient acknowledges and agrees that (a)&nbsp;as a result of the Recipient&#146;s
previous, current and future employment with the Company, the Recipient has had access to, will have access to and/or possesses or will possess confidential and proprietary information of Coherent and its Subsidiaries, (b)&nbsp;Coherent and its
Subsidiaries are engaged in a highly competitive business and conduct such business worldwide, (c)&nbsp;this Agreement does not constitute a contract of employment, does not imply that the Company will continue the Recipient&#146;s employment for
any period of time and does not change the <FONT STYLE="white-space:nowrap">at-will</FONT> nature of the Recipient&#146;s employment, except as set forth in a separate written employment agreement between the Company and the Recipient, (d)&nbsp;the
restrictive covenants set forth in <U>Section</U><U></U><U>&nbsp;14</U> are necessary and reasonable in time and scope (including the period, geographic, product and service and other restrictions) to protect the legitimate business interests of
Coherent and its Subsidiaries, (e)&nbsp;the remedy, forfeiture and payment provisions contained in <U>Section</U><U></U><U>&nbsp;16</U> are reasonable and necessary to protect the legitimate business interests of Coherent and its Subsidiaries,
(f)&nbsp;acceptance of this Award and the Restricted Share Units and agreement to be bound by the provisions hereof is not a condition of the Recipient&#146;s employment and (g)&nbsp;the Recipient&#146;s receipt of the benefits provided under this
Agreement is adequate consideration for the enforcement of the provisions contained in <U>Section</U><U></U><U>&nbsp;14</U> and <U>Section</U><U></U><U>&nbsp;16</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">18. <U>Severability; Waiver</U>. If any term, provision, covenant or restriction contained in this Agreement is held by a
court or a federal regulatory agency of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions contained in this Agreement shall remain in full force and effect, and shall in
no way be affected, impaired or invalidated. In particular, in the event that any of such provisions shall be adjudicated to exceed the time, geographic, product and service or other limitations permitted by applicable law in any jurisdiction, then
such provisions shall be deemed reformed in such jurisdiction to the maximum time, geographic, product and service or other limitations permitted by applicable law. No delay or omission by Coherent in exercising any right under this Agreement will
operate as a waiver of that or any other right. A waiver or consent given by Coherent on any one occasion is effective only in that instance and will not be construed as a bar to or waiver of any right on any other occasion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">19. <U>Notice</U>. Coherent may require any notice required or permitted under this Agreement to be transmitted, submitted or
received, by Coherent or the Recipient, via the Solium Shareworks System in accordance with the procedures established by Coherent for such notice. Otherwise, except as otherwise set forth in this Agreement, any written notice required or permitted
by this Agreement shall be mailed, certified mail (return receipt requested) or by overnight carrier, to Coherent at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Coherent Corp. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Chief
Financial Officer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">375 Saxonburg Boulevard </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Saxonburg, Pennsylvania 16056 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">or
to the Recipient at his or her most recent home address on record with Coherent. Notices are effective upon receipt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">20.
<U>Controlling Law</U>. The validity, construction and effect of this Agreement will be determined in accordance with the internal laws of the Commonwealth of Pennsylvania without giving effect to the conflict of laws principles thereof. The
Recipient and Coherent hereby irrevocably submit to the exclusive jurisdiction of the state and Federal courts located in the Commonwealth of Pennsylvania and consent to the jurisdiction of any such court; provided, however, that, notwithstanding
anything to the contrary set forth above, Coherent may file an action to enforce the covenants contained in <U>Section</U><U></U><U>&nbsp;14</U> by seeking injunctive or other equitable relief in any appropriate court having jurisdiction, including
where the Recipient resides or where the Recipient was employed by the Company. The Recipient and Coherent also both irrevocably waive, to the fullest extent permitted by applicable law, any objection either may now or hereafter have to the laying
of venue of any such dispute brought or injunctive or equitable relief sought in such court or any defense of inconvenient forum for the maintenance of such dispute and consent to the personal jurisdiction of any such court. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">21. <U>Entire Agreement</U>. This Agreement (including the Plan and the Employee Grant Details), together with the Offer
Letter provisions regarding Recipient&#146;s inducement awards, contains the entire understanding between the parties and supersedes any prior understanding and agreements between them regarding the subject matter hereof with respect to this Award,
and there are no other representations, agreements, arrangements or understandings, oral or written, between the parties relating to this Award which are not fully expressed herein. Notwithstanding anything to the contrary set forth in this
Agreement, any restrictive covenants contained in this Agreement are independent, and are not intended to limit the enforceability, of any restrictive or other covenants contained in any other agreement between the Company and the Recipient. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">22. <U>Captions; Section</U><U></U><U>&nbsp;References</U>. Section&nbsp;and other headings contained in this Agreement are
for reference purposes only and are in no way intended to describe, interpret, define or limit the scope, extent or intent of this Agreement or any provision hereof. Unless expressly provided otherwise, any reference in this Agreement to any
Section&nbsp;refers to the corresponding Section&nbsp;of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">23. <U>Limitation of Actions</U>. Any lawsuit
commenced by the Recipient with respect to any matter arising out of or relating to this Agreement must be filed no later than one (1)&nbsp;year after the date that a denial of any claim hereunder is made or any earlier date that the claim otherwise
accrues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">24. <U>Section</U><U></U><U>&nbsp;409A</U>. This Agreement and this Award are intended to satisfy all applicable
requirements of Section&nbsp;409A or an exception thereto and shall be construed accordingly. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Coherent may in its sole discretion, and without the Recipient&#146;s consent, take any action it deems necessary to comply with the requirements of Section&nbsp;409A or an exception thereto,
including amending the terms of this Award and this Agreement, in any manner it deems necessary to cause this Award and this Agreement to be excepted from Section&nbsp;409A (or to comply therewith to the extent that Coherent determines that it is
not excepted). Notwithstanding, the Recipient recognizes and acknowledges that Section&nbsp;409A may affect the timing and recognition of payments due hereunder, and may impose upon the Recipient certain taxes or other charges for which the
Recipient is and shall remain solely responsible. Notwithstanding anything to the contrary in this Agreement, if the Recipient is a Specified Employee, to the extent that the Award constitutes &#147;nonqualified deferred compensation&#148; subject
to Section&nbsp;409A of the Code, any payment due to the Recipient under the Award upon Separation from Service will be delayed in accordance with Section&nbsp;18 of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">25. <U>Assignment</U>. Except as provided in <U>Section</U><U></U><U>&nbsp;6</U>, the Recipient&#146;s rights and obligations
under this Agreement shall not be transferable by the Recipient, by assignment or otherwise, and any purported assignment, transfer or delegation thereof by the Recipient shall be void. Coherent may assign/delegate all or any portion of this
Agreement and its respective rights hereunder without prior notice to the Recipient and without the Recipient providing any additional consent thereto, whereupon the Recipient shall continue to be bound hereby with respect to such
assignee/delegatee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">26. <U>Electronic Delivery</U>. Coherent may, in its sole discretion, deliver any documents or
correspondence related to this Agreement, the Restricted Share Units, the Plan, the Recipient&#146;s participation in the Plan or <B>future awards that may be granted to the Recipient under the Plan, by electronic means. The Recipient hereby
consents to receive such documents by electronic delivery and to the Recipient</B><B>&#146;</B><B>s participation in the Plan through an <FONT STYLE="white-space:nowrap">on-line</FONT> or electronic system established and maintained by Coherent or
another third party designated by Coherent, including the </B><B>Solium</B><B> </B><B>Shareworks</B><B> System. Likewise, Coherent</B> may require the Recipient to deliver or receive any documents or correspondence related to this Agreement by such
electronic means. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">27. <U>Further Assurances</U>. The Company and the Recipient shall use commercially reasonable efforts
to, from time to time at the request of the other party, without any additional consideration, furnish the other party such further information or assurances, execute and deliver such additional documents and take such other actions and do such
other things, as may be necessary to carry out the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">28. <U>Compliance with Legal
Requirements</U>. Notwithstanding any other provisions of the Plan or this Agreement, unless there is an exemption from any registration, qualification or other legal requirement applicable to the Shares, the Company shall not be required to deliver
any Shares issuable upon vesting of this Award prior to the completion of any registration or qualification of the Shares under any local, state, federal or foreign securities or exchange control law or under rulings or regulations of the U.S.
Securities and Exchange Commission (&#147;<I>SEC</I>&#148;) or of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
any other governmental regulatory body, or prior to obtaining any approval or other clearance from any local, state, federal or foreign governmental agency, which registration, qualification or
approval the Company shall, in its absolute discretion, deem necessary or advisable. Further, the Company is under no obligation to register or qualify the Shares with the SEC or any state or foreign securities commission or to seek approval or
clearance from any governmental authority for the issuance or sale of Shares. Subject to Section&nbsp;409A, the Committee may postpone the issuance or delivery of Shares under this Award as the Committee may consider appropriate and may require the
Recipient to make such representations and furnish such information as it may consider appropriate in connection with the issuance or delivery of Shares in compliance with applicable laws, rules and regulations. The Recipient understands and agrees
that the Company shall have unilateral authority to amend this Agreement without his or her consent to the extent necessary to comply with securities or other laws applicable to the issuance of Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">29. <U>Imposition of Other Requirements</U>. The Company reserves the right to impose other requirements on this Award to the
extent that the Company determines that it is necessary or advisable in order to comply with local law or facilitate the administration of this Award and to require the Recipient to sign any additional agreements or undertakings that may be
necessary to accomplish the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">30. <U>No Advice Regarding Grant</U>. The Company is not providing any tax, legal
or financial advice, nor is the Company making any recommendations regarding the Recipient&#146;s participation in the Plan or the Recipient&#146;s acquisition or sale of Shares. The Recipient understands and agrees that the Recipient should consult
with his or her own personal legal and financial advisors regarding the Recipient&#146;s participation in the Plan before taking any action related to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">31. <U>Amendments</U>. This Agreement may be amended or modified at any time by an instrument in writing signed by the parties
hereto, or as otherwise provided under the Plan or this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGE FOLLOWS] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">IN WITNESS WHEREOF, the parties have executed this Agreement as of the Grant
Date set forth above. Electronic acceptance of this Agreement by the Recipient pursuant to Coherent&#146;s instructions to the Recipient (including through the Solium Shareworks System) shall constitute execution of this Agreement by the Recipient.
The Recipient agrees that his or her electronic acceptance of this Agreement, including via the Solium Shareworks System, shall constitute his or her signature, and that he or she agrees to be bound by all of the terms and conditions of this
Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">COHERENT CORP.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Chiew Mee Yong</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Chief Human Resources Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">RECIPIENT</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Electronic Acceptance via the</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Solium Shareworks System</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Restricted Share Units) </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>d845190dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COHERENT CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDUCEMENT AWARD AGREEMENT (PERFORMANCE SHARE UNITS) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">THIS INDUCEMENT AWARD AGREEMENT (PERFORMANCE SHARE UNITS) (this <I>&#147;</I><I>Agreement</I><I>&#148;</I><I>) </I>is dated as
of June&nbsp;3, 2024 (the &#147;<I>Grant Date</I>&#148;) by and between Coherent Corp., a Pennsylvania corporation <I>(</I><I>&#147;</I><I>Coherent</I><I>&#148;</I><I>)</I>, and the JAMES R. ANDERSON, the newly hired Chief Executive Officer of
Coherent (the <I>&#147;</I><I>Recipient</I><I>&#148;</I><I>)</I>, all as contemplated by the offer letter of employment by and between Coherent and Recipient dated May&nbsp;31, 2024 (the &#147;<I>Offer Letter</I>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Reference is made to the Employee Grant Details found on the Solium Shareworks system at https://Shareworks.Solium.com (or any
successor system selected by Coherent) (the <I>&#147;Solium Shareworks System&#148;</I>). Employee Grant Details for a specific Award can be found by clicking on such Award listed in the Stock Options and Awards section under the Portfolio tab (the
<I>&#147;Employee Grant Details&#148;</I>) of the Solium Shareworks System. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Award constitutes a <FONT
STYLE="white-space:nowrap">non-plan</FONT> &#147;employment inducement award&#148; as contemplated by New York Stock Exchange Listing Rule 303A.08 and is therefore not made pursuant to the Coherent Corp. Omnibus Incentive Plan as amended and
restated effective November&nbsp;9, 2023 (as may be amended and/or restated from time to time, the <I>&#147;Plan&#148;)</I>. Nonetheless, the terms and provisions of the Plan are hereby incorporated into this Agreement by this reference, as though
fully set forth herein, as if this Award was granted pursuant to the Plan. Capitalized terms used but not defined herein will have the same meaning as defined in the Plan. A copy of the Plan can be found on the Solium Shareworks System, and/or the
applicable Employee Grant Details. Reference further is made to the prospectus relating to the Plan, which also may be found on the Solium Shareworks System. This Agreement shall constitute an Award Agreement as that term is defined in the Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>NOW, THEREFORE, </B>for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,
and intending to be legally bound hereby, the Recipient and Coherent agree as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1. <U>Inducement Award &#150;
Performance Share Units</U>. Coherent hereby grants to the Recipient an Award of Performance Share Units, as specified in the Employee Grant Details, to be earned based upon achievement of the Performance Objectives in accordance with
<U>Section</U><U></U><U>&nbsp;2</U> (this <I>&#147;Award&#148;</I>). For the purposes of this Award: (1)<I>&nbsp;&#147;Performance Period&#148;</I> shall mean the period from June&nbsp;3, 2024 through and including June&nbsp;30, 2027;<B>
</B>(2)<I>&nbsp;&#147;Target Award&#148;</I> shall mean the Target Award set forth in the Employee Grant Details; (3)<I>&nbsp;&#147;Maximum Award&#148;</I> means the maximum number of Shares that may be earned under this Agreement as set forth in
the Employee Grant Details, which number represents 250% of the Target Award; and (4) <I>&#147;Performance Share Unit&#148;</I> or <I>&#147;Unit&#148;</I> means the contingent right to receive the equivalent of one (1)&nbsp;Share, in the event the
Unit vests and becomes payable pursuant to the terms of this Agreement. Units shall be payable and settled solely in Shares, except as otherwise provided in this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2. <U>Determination of Units Earned</U>. Subject to
<U>Section</U><U></U><U>&nbsp;4</U> and <U>Section</U><U></U><U>&nbsp;5</U>, the Units shall be earned in accordance with the following schedule: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Performance Level</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Units Earned as a<BR>Percentage&nbsp;of&nbsp;Target&nbsp;Award<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">If Cumulative TSR is below Market 25<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>
Percentile</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">0.00%<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Below&nbsp;Threshold)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">If Cumulative TSR is equal to Market 25<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>
Percentile</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">50.00%<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Threshold&nbsp;Award)</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">If Cumulative TSR is equal to Market 55<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>
Percentile</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">100.00%<SUP STYLE="font-size:75%; vertical-align:top">2</SUP><BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Target Award)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">If Cumulative TSR is equal to Market 75<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>
Percentile or greater</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">250.00%<SUP STYLE="font-size:75%; vertical-align:top">2</SUP><BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Maximum&nbsp;Award)</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">If performance is between threshold and target or between target and maximum, the percentage of the Target
Award earned shall be interpolated on a straight-line basis. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">If there is an absolute negative Cumulative TSR for the Performance Period and Cumulative TSR is above
Market 50th Percentile, the percentage of the Target Award earned shall be capped at 100.00%. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Definitions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>&#147;</I><I>Market</I><I>&#148;</I> is the S&amp;P Composite 1500 &#150; Electronic Equipment, Instruments&nbsp;&amp;
Components as published on June&nbsp;3, 2024. If a listing is removed from the S&amp;P Composite 1500 &#150; Electronic Equipment, Instruments&nbsp;&amp; Components during the Performance Period, it will not be replaced, nor will any listing be
added for any other reason. The S&amp;P Composite 1500 &#150; Electronic Equipment, Instruments&nbsp;&amp; Components shall be a closed group for purposes of this Program. Notwithstanding the foregoing, if a company ceases to be publicly traded as a
result of insolvency or a bankruptcy proceeding, it shall be included in the Market as the lowest performing company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>&#147;Cumulative TSR&#148;</I> shall be based on the <FONT STYLE="white-space:nowrap">30-day</FONT> average closing stock
price of the Shares prior to June&nbsp;3, 2024 ($xx.xx) (<I>&#147;Beginning Stock Price&#148;</I>) and the <FONT STYLE="white-space:nowrap">30-day</FONT> average closing stock price of the Shares prior to July&nbsp;1, 2027 (<I>&#147;Ending Stock
Price&#148;</I>). Cumulative TSR shall be calculated as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">((Ending Stock Price minus Beginning Stock Price ($xx.xx)
plus dividends) divided by Beginning Stock Price ($xx.xx)) </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Only whole Units shall be earned in accordance with this
<U>Section</U><U></U><U>&nbsp;2</U>. By way of example and not limitation, earning 66.67% of a Target Award of 100 Units would result in 66 Units being earned and payable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3. <U>Payment; Dividend Equivalents</U>. The amount determined under
<U>Section</U><U></U><U>&nbsp;2</U> will be paid to the Recipient in Shares no later than the seventy-fifth (75th) calendar day following the end of the Performance Period. Coherent shall cause a stock certificate (or equivalent electronic book
entry) representing Shares equal to the number of Units vested and payable under this Agreement to be issued to the Recipient by such date. In addition, the Recipient shall be entitled to receive, following the completion of the Performance Period
but in no event later than March 15th of the calendar year following the completion of the Performance Period, a cash payment equal to the cash dividends that would have been paid during the Performance Period on the applicable number of Shares
underlying the Units earned as provided in <U>Section</U><U></U><U>&nbsp;2</U> if such Shares had been issued and outstanding during the Performance Period. Such cash dividend equivalents will not vest or be paid prior to the vesting of the Units to
which they relate, as specified in this Agreement, and will be subject to cancellation and forfeiture to the same extent that the related Units do not vest or are forfeited. Notwithstanding the foregoing, the Company, at its sole discretion, may
settle the Award in cash if necessary or appropriate for legal or administrative reasons based on laws in the Recipient&#146;s jurisdiction, in which case the Company shall pay to the Recipient an amount in cash equal to the product of (a)&nbsp;the
number of Units earned in accordance with <U>Section</U><U></U><U>&nbsp;2</U> and (b)&nbsp;the Fair Market Value on the day prior to the Committee&#146;s approval of the number of Units earned following completion of the Performance Period, with
such cash payment being made to the Recipient no later than the seventy fifth (75th) calendar day following the end of the Performance Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">4. <U>Separation from Service</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) <U>General</U>. Except as provided in <U>Section</U><U></U><U>&nbsp;4(b)</U> or <U>Section</U><U></U><U>&nbsp;5</U> or as
may be otherwise determined by the Committee, if the Recipient&#146;s Separation from Service occurs before the end of the Performance Period, this Award shall be forfeited on the date of such Separation from Service and the Recipient shall not be
entitled to any compensation for lost vesting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) <U>Prorating in Certain Circumstances</U>. Notwithstanding
Section&nbsp;4(a), if the Recipient&#146;s Separation from Service occurs during the Performance Period due to the Recipient&#146;s (i)&nbsp;normal retirement, as defined in Coherent&#146;s Global Retirement Policy, (ii)&nbsp;death, (iii) permanent
and total disability, as defined in Code Section&nbsp;22(e)(3) (a &#147;<I>Disability</I>&#148;), (iv) termination by the Company other than for Cause (as defined below) other than within two years following a Change in Control or
(v)&nbsp;termination by the Recipient for Good Reason (as defined below) other than within two years following a Change in Control, but only if the Recipient&#146;s offer letter, employment agreement or other applicable employment or service
agreement with the Company provides for severance upon Separation from Service for Good Reason (or similar term), then in each case under clauses (i) <FONT STYLE="white-space:nowrap">-</FONT> (v) of this paragraph, the Recipient shall be entitled to
a prorated portion of the Units to the extent earned pursuant to Section&nbsp;2, determined at the end of the Performance Period and based on the ratio of the number of complete months the Recipient was employed or served (as applicable) during the
Performance Period to the total number of months in the Performance Period. In the event of the death of the Recipient, delivery of the applicable number of Shares shall be made to the Recipient&#146;s estate as soon as
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
administratively practicable after the end of the Performance Period. Notwithstanding the foregoing, in the event of the Recipient&#146;s &#147;Qualifying Termination&#148; during a <FONT
STYLE="white-space:nowrap">&#147;Non-CIC</FONT> Period&#148; (as those terms are defined in the Offer Letter), and consistent with the requirements of <U>Exhibit C</U> to the Offer Letter, (i)&nbsp;a prorated portion of the Units shall be determined
by adding an additional 12 months of service, (ii)&nbsp;such prorated Units shall be adjusted based on the greater of target or actual performance, determined under Section&nbsp;2 as if the Performance Period ended on the date of the Qualifying
Termination, and (iii)&nbsp;such earned and vested Units shall be settled as soon as administratively practicable after the release described in the Offer Letter becomes effective (and in no event later than 75 days after the date of the Qualifying
Termination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">5. <U>Change in Control; Adjustments to Payments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><U>(a)</U> <U>Change in Control</U>. Upon a Change in Control, the Award shall be treated in accordance with Section&nbsp;10 of
the Plan, or, if better, in accordance with <U>Exhibit C</U> to the Offer Letter for a Qualifying Termination during a CIC Period, with &#147;Cause&#148; and &#147;Good Reason&#148; for such purpose as defined in the Offer Letter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><U>(b)</U> <U>Adjustments to Payments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) Notwithstanding any provision to the contrary in this Agreement, if it is determined that any payment or distribution by
the Company to the Recipient or for the Recipient&#146;s benefit (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise) (the <I>&#147;Payments&#148;</I>) would be subject to the excise tax
imposed by Code Section&nbsp;4999, or any interest or penalty is incurred by the Recipient with respect to such excise tax (such excise tax, together with any such interest and penalties, collectively referred to as the <I>&#147;Excise
Tax&#148;</I>), then the Payments shall be reduced (but not below zero) if and to the extent that such reduction would result in the Recipient retaining a larger amount, on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis (taking into
account federal, state and local income taxes and the imposition of the Excise Tax), than if the Recipient received all of the Payments. The Company shall reduce or eliminate the Payments by first reducing or eliminating the portion of the Payments
that are not payable in cash and then by reducing or eliminating cash payments, in each case in reverse order beginning with payments or benefits that are to be paid the farthest in time from the determination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) All determinations required to be made under this <U>Section</U><U></U><U>&nbsp;5(d)</U>, including whether and when an
adjustment to any Payments is required and, if applicable, which Payments are to be so adjusted, shall be made by an independent accounting firm selected by Coherent from among the four (4)&nbsp;largest accounting firms in the United States or any
nationally-recognized financial planning and benefits consulting company (the <I>&#147;Accounting Firm&#148;</I>), which shall provide detailed supporting calculations both to Coherent and to the Recipient within fifteen (15)&nbsp;business days of
the receipt of notice from the Recipient that there has been a Payment, or such earlier time as is requested by Coherent. In the event that the Accounting Firm is serving as accountant or auditor for the individual, entity or group effecting the
Change in Control, Coherent shall appoint another nationally-recognized accounting firm to make the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
determinations required hereunder (which accounting firm shall then be referred to as the Accounting Firm hereunder). All fees and expenses of the Accounting Firm shall be borne solely by
Coherent. If the Accounting Firm determines that no Excise Tax is payable by the Recipient, it shall furnish the Recipient with a written opinion that failure to report the Excise Tax on the Recipient&#146;s applicable federal income tax return
would not result in the imposition of a negligence or similar penalty. Any determination by the Accounting Firm shall be binding upon the Company and the Recipient. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6. <U>Nontransferability</U>. Except as otherwise provided in the Plan, the Units shall not be sold, pledged, assigned,
hypothecated, transferred or disposed of (a <I>&#147;Transfer&#148;) </I>in any manner, other than by will or the laws of descent and distribution. Any attempt to Transfer the Units in violation of this Section or the Plan shall render this Award
null and void. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">7. <U>Adjustments</U>. Upon any event described in Section&nbsp;12 of the Plan (entitled
&#147;<I>Adjustments</I>&#148;) or any successor provision thereto, the terms of such Section&nbsp;12 of the Plan or any successor provision thereto shall apply to this Award. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">8. <U>Fractional Shares</U>. Coherent shall not be required to issue any fractional Shares pursuant to this Award, and Coherent
may round fractional Shares down to the nearest whole Share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">9. <U>Responsibility for Taxes</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) Regardless of any action the Company takes with respect to any or all income tax, social insurance, payroll tax, fringe
benefit tax, payment on account or other <FONT STYLE="white-space:nowrap">tax-related</FONT> items related to the Recipient&#146;s participation in the Plan (<I><FONT STYLE="white-space:nowrap">&#147;Tax-Related</FONT> Items&#148;</I>), the
Recipient acknowledges that the ultimate liability for all <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items owed by the Recipient is and remains the Recipient&#146;s responsibility and that the Company (i)&nbsp;makes no representations or
undertakings regarding the treatment of any <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items in connection with any aspect of this Award, including the grant or vesting of this Award or the subsequent sale of Shares acquired pursuant to
this Award; and (ii)&nbsp;does not commit to structure the terms of the grant or any aspect of this Award to reduce or eliminate the Recipient&#146;s liability for <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items or achieve a particular tax
result. Further, if the Recipient is subject to <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items in more than one jurisdiction, the Recipient acknowledges and agrees that the Company may be required to withhold or account for <FONT
STYLE="white-space:nowrap">Tax-Related</FONT> Items in more than one jurisdiction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) Prior to any relevant taxable or
tax withholding event, as applicable, the Recipient agrees to make adequate arrangements satisfactory to the Company to satisfy all <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items. In this regard, the Recipient authorizes the Company, or
their respective agents, at their discretion, to satisfy any applicable withholding obligations with regard to <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items by one or a combination of the following: (i)&nbsp;withholding from the
Recipient&#146;s wages or other cash compensation paid to the Recipient by the Company; (ii)&nbsp;withholding from the proceeds of the sale of Shares acquired upon vesting of this Award either through a voluntary sale or through a mandatory sale
arranged by the Company (on the Recipient&#146;s behalf pursuant to this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
authorization) without further consent; (iii)&nbsp;withholding Shares to be issued upon vesting of this Award; or (iv)&nbsp;any other method determined by the Committee and permitted by
applicable laws. Notwithstanding the foregoing, if the Recipient is subject to the short-swing profit rules of Section&nbsp;16(b) of the Exchange Act, the Company will withhold in Shares issuable at vesting of the Award upon the relevant withholding
event, unless otherwise determined by the Committee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) The Company may withhold or account for <FONT
STYLE="white-space:nowrap">Tax-Related</FONT> Items by considering applicable withholding rates, including maximum applicable rates, in which case the Recipient may receive a refund of any over-withheld amount in cash (with no entitlement to the
equivalent in Shares) or, if not refunded, the Recipient may seek a refund from the local tax authorities. In the event of under-withholding, the Recipient may be required to pay any additional <FONT STYLE="white-space:nowrap">Tax-Related</FONT>
Items directly to the applicable tax authority or to the Company. If the obligation for <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items is satisfied by withholding in Shares, for tax purposes, the Recipient is deemed to have been issued
the full number of Shares, notwithstanding that a number of Shares is held back solely for the purpose of paying the <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) Finally, the Recipient shall pay to the Company any amount of <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items
that the Company may be required to withhold or account for as a result of the Recipient&#146;s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver Shares or the proceeds
from the sale of Shares if the Recipient fails to comply with the Recipient&#146;s obligations in connection with the <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items as described in this <U>Section</U><U></U><U>&nbsp;9</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">10. <U>Plan Provisions</U>. In the event of any conflict between the provisions of this Agreement and the Plan, the Plan shall
control, except that capitalized terms specifically defined in this Agreement shall have the meaning given to them in this Agreement with respect to their usage in this Agreement, notwithstanding the definitions given to such terms in the Plan
(which definitions shall control as they relate to the usage of such terms in the Plan). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">11. <U>No Continued Rights</U>.
The granting of this Award shall not give the Recipient any rights to similar grants in future years or any right to continuance of employment or other service with Coherent or its Subsidiaries, nor shall it interfere in any way with any right that
the Company would otherwise have to terminate the Recipient&#146;s employment or other service at any time, or the right of the Recipient to terminate his or her employment or other service at any time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">12. <U>Rights Unsecured</U>. The Recipient shall have only Coherent&#146;s unfunded, unsecured promise to pay pursuant to the
terms of this Agreement. The rights of the Recipient hereunder shall be that of a general unsecured creditor of Coherent and the Recipient shall not have any security interest in any assets of Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">13. <U>Restrictive Covenants</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) While the Recipient is employed by the Company (including its
Subsidiaries) and for a period of one (1)&nbsp;year after the Recipient&#146;s Separation from Service for any reason (the &#147;<I>Restricted Period</I>&#148;), the Recipient will not directly or indirectly either alone or in association with
others solicit, or permit any organization directly or indirectly controlled by the Recipient to solicit, any employee or independent contractor of Coherent or its Subsidiaries to leave the employ or service of Coherent or its Subsidiaries. The
Restricted Period will be tolled during and for any period of time during which the Recipient is in violation of the restrictive covenants contained in this <U>Section</U><U></U><U>&nbsp;13(a)</U> and for any period of time which may be necessary to
secure an order of court or injunction, either preliminary or permanent, to enforce such covenants, such that the cumulative time period during which the Recipient is in compliance with the restrictive covenants contained in this
<U>Section</U><U></U><U>&nbsp;13(a)</U> will not exceed the one (1)-year period set forth above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) The Recipient
acknowledges that certain materials, including information, data, technology and other materials relating to customers, programs, costs, marketing, investment, sales activities, promotion, credit and financial data, manufacturing processes,
financing methods, plans or the business and affairs of Coherent and its Subsidiaries constitute proprietary confidential information and trade secrets. Accordingly, the Recipient will not at any time during or after the Recipient&#146;s employment
with the Company or a Subsidiary disclose or use for the Recipient&#146;s own benefit or purposes or the benefit or purposes of any other person, firm, partnership, joint venture, association, corporation or other business organization, entity or
enterprise, other than the Company (including its Subsidiaries), any proprietary confidential information or trade secrets; provided that the foregoing shall not apply to information which is not unique to Coherent and its Subsidiaries or which is
generally known to the industry or the public other than as a result of the Recipient&#146;s breach of this covenant. The Recipient agrees that, upon the Recipient&#146;s Separation from Service for any reason, the Recipient will immediately return
to Coherent all property of Coherent and its Subsidiaries including all memoranda, books, technical and/or lab notebooks, customer product and pricing data, papers, plans, information, letters and other data, and all copies thereof or therefrom,
which in any way relate to the business of Coherent and its Subsidiaries, except that the Recipient may retain personal items. The Recipient further agrees that the Recipient will not retain or use for the Recipient&#146;s account at any time any
trade names, trademark or other proprietary business designation used or owned in connection with the business of Coherent and its Subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) Nothing herein is intended to or shall limit, prevent, impede or interfere with the Recipient&#146;s <FONT
STYLE="white-space:nowrap">non-waivable</FONT> right, without prior notice to the Company, to provide information to the government, participate in investigations, testify in proceedings regarding the Company&#146;s past or future conduct, or engage
in any activities protected under whistleblower statutes, or to receive and fully retain a monetary award from a government-administered whistleblower award program for providing information directly to a government agency. Further, the Recipient
understands that pursuant to the Defend Trade Secrets Act of 2016, the Recipient shall not be held criminally, or civilly, liable under any Federal or State trade secret law for the disclosure of a trade secret that is made in confidence either
directly or indirectly to a Federal, State, or local government official, or an attorney, for the sole purpose of reporting, or investigating, a violation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
of law. Moreover, the Recipient understands that he or she may disclose trade secrets in a complaint, or other document, filed in a lawsuit, or other proceeding, if such filing is made under
seal. Finally, the Recipient understands that if he or she files a lawsuit alleging retaliation by the Company for reporting a suspected violation of the law, the Recipient may disclose the trade secret to the attorney and use the trade secret in
the court proceeding, so long as any document containing the trade secret is filed under seal and the Recipient does not disclose the trade secret except pursuant to court order. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">14. <U>Data Collection and Usage</U>. Pursuant to applicable data protection laws, the Recipient is hereby notified that the
Company collects, processes, uses and transfers certain personally-identifiable information about the Recipient for the exclusive legitimate purpose of granting Performance Share Units and implementing, administering and managing the
Recipient&#146;s participation in the Plan. For California residents, the categories of personal, including sensitive personal information, are identifiers, characteristics of protected classifications under California or federal law, professional
or employment related information, social security, driver&#146;s license, state identification card, or passport number, and any personal information that identifies, relates to, describes, or is capable of being associated with a particular
individual. The personal information is not sold or shared for cross-context behavioral advertising. For additional information, please see Exhibit E of the Global Employee Data Privacy Policy and Notice which can be found at: Policy <FONT
STYLE="white-space:nowrap">Center&#151;PVY-001</FONT> Employee Privacy Policy and Notice&#151;All Documents (sharepoint.com). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">15. <U>Remedies; Clawback</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) Coherent and the Recipient acknowledge and agree that that any violation by the Recipient of any of the restrictive
covenants contained in <U>Section</U><U></U><U>&nbsp;13</U> would cause immediate, material and irreparable harm to Coherent and its Subsidiaries which may not adequately be compensated by money damages and, therefore, Coherent and its Subsidiaries
shall be entitled to injunctive relief (including one (1)&nbsp;or more preliminary injunctions and/or ex parte restraining orders) in addition to, and not in derogation of, any other remedies provided by law, in equity or otherwise for such a
violation, including the right to have such covenants specifically enforced by any court of competent jurisdiction, the rights under <U>Section</U><U></U><U>&nbsp;15(b)</U>, and the right to require the Recipient to account for and pay over to
Coherent all benefits derived or received by the Recipient as a result of any such breach of covenant together with interest thereon, from the date of such initial violation until such sums are received by Coherent. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) In the event that the Recipient violates or breaches any of the covenants set forth in
<U>Section</U><U></U><U>&nbsp;13</U>, the Units and the right to receive Shares in exchange for such Units shall be forfeited. Coherent shall also have the right, in its sole discretion, in addition to any other remedies or damages provided by law,
in equity or otherwise, to demand and require the Recipient, (i)&nbsp;to the extent that any cash payment was received with respect to such Units, to return and transfer to Coherent any such cash payment, (ii)&nbsp;to the extent that any Shares were
received with respect to such Units, to return and transfer to Coherent any such shares directly </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
or beneficially owned by the Recipient, and (iii)&nbsp;to the extent that the Recipient sold or transferred any such Shares, to disgorge and/or repay to Coherent any profits or other economic
value (as determined by Coherent) made or realized by the Recipient with respect to such Shares, including the value of any gift thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) This Award, <B>and any amounts or benefits received or outstanding under the Plan, as well as any other incentive awards
previously granted to the Recipient by the Company</B>, shall be subject to potential clawback, cancellation, recoupment, rescission, payback, reduction, or other similar action in accordance with the terms or conditions of any applicable Company
clawback or similar policy or any applicable law related to such actions, as may be in effect from time to time, including the requirements of (a)&nbsp;Section&nbsp;304 of the Sarbanes Oxley Act and Section&nbsp;954 of the Dodd-Frank Wall Street
Reform and Consumer Protection Act (including any rules implementing those statutory requirements adopted under the Exchange Act or by the applicable exchange on which Shares are listed), (b) similar rules under the laws of any other jurisdiction,
and (c)&nbsp;any policies adopted by the Company to implement such requirements. The Recipient acknowledges and consents to the Company&#146;s application, implementation and enforcement of any applicable Company clawback or similar policy that may
apply to the Recipient, whether adopted prior to or following the Grant Date, and any provision of applicable law relating to clawback, cancellation, recoupment, rescission, payback, or reduction of compensation, and agrees that the Company may take
such actions as may be necessary to effectuate any such policy or applicable law, without further consideration or action. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">16. <U>Recipient Acknowledgments</U>. The Recipient acknowledges and agrees that (a)&nbsp;as a result of the Recipient&#146;s
previous, current and future employment with the Company, the Recipient has had access to, will have access to and/or possesses or will possess confidential and proprietary information of Coherent and its Subsidiaries, (b)&nbsp;Coherent and its
Subsidiaries are engaged in a highly competitive business and conduct such business worldwide, (c)&nbsp;this Agreement does not constitute a contract of employment, does not imply that the Company will continue the Recipient&#146;s employment for
any period of time and does not change the <FONT STYLE="white-space:nowrap">at-will</FONT> nature of the Recipient&#146;s employment, except as set forth in a separate written employment agreement between the Company and the Recipient, (d)&nbsp;the
restrictive covenants set forth in <U>Section</U><U></U><U>&nbsp;13</U> are necessary and reasonable in time and scope (including the period, geographic, product and service and other restrictions) to protect the legitimate business interests of
Coherent and its Subsidiaries, (e)&nbsp;the remedy, forfeiture and payment provisions contained in <U>Section</U><U></U><U>&nbsp;15</U> are reasonable and necessary to protect the legitimate business interests of Coherent and its Subsidiaries,
(f)&nbsp;acceptance of this Award and these Units and agreement to be bound by the provisions hereof is not a condition of the Recipient&#146;s employment and (g)&nbsp;the Recipient&#146;s receipt of the benefits provided under this Agreement is
adequate consideration for the enforcement of the provisions contained in <U>Section</U><U></U><U>&nbsp;13</U> and <U>Section</U><U></U><U>&nbsp;15</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">17. <U>Severability; Waiver</U>. If any term, provision, covenant or restriction contained in this Agreement is held by a court
or a federal regulatory agency of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
contained in this Agreement shall remain in full force and effect, and shall in no way be affected, impaired or invalidated. In particular, in the event that any of such provisions shall be
adjudicated to exceed the time, geographic, product and service or other limitations permitted by applicable law in any jurisdiction, then such provisions shall be deemed reformed in such jurisdiction to the maximum time, geographic, product and
service or other limitations permitted by applicable law. No delay or omission by Coherent in exercising any right under this Agreement will operate as a waiver of that or any other right. A waiver or consent given by Coherent on any one occasion is
effective only in that instance and will not be construed as a bar to or waiver of any right on any other occasion. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">18.
<U>Notice</U>. Coherent may require any notice required or permitted under this Agreement to be transmitted, submitted or received, by Coherent or the Recipient, via the Solium Shareworks System in accordance with the procedures established by
Coherent for such notice. Otherwise, except as otherwise set forth in this Agreement, any written notice required or permitted by the Agreement shall be mailed, certified mail (return receipt requested) or by overnight carrier, to Coherent at the
following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Coherent Corp. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Chief Financial Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">375 Saxonburg Boulevard </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Saxonburg,
Pennsylvania 16056 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">or to the Recipient at his or her most recent home address on record with Coherent. Notices are effective upon
receipt. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">19. <U>Controlling Law</U>. The validity, construction and effect of this Agreement will be determined in
accordance with the internal laws of the Commonwealth of Pennsylvania without giving effect to the conflict of laws principles thereof. The Recipient and Coherent hereby irrevocably submit to the exclusive jurisdiction of the state and Federal
courts located in the Commonwealth of Pennsylvania and consent to the jurisdiction of any such court; provided, however, that, notwithstanding anything to the contrary set forth above, Coherent may file an action to enforce the covenants contained
in <U>Section</U><U></U><U>&nbsp;13</U> by seeking injunctive or other equitable relief in any appropriate court having jurisdiction, including where the Recipient resides or where the Recipient was employed by the Company. The Recipient and
Coherent also both irrevocably waive, to the fullest extent permitted by applicable law, any objection either may now or hereafter have to the laying of venue of any such dispute brought or injunctive or equitable relief sought in such court or any
defense of inconvenient forum for the maintenance of such dispute and consent to the personal jurisdiction of any such court. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">20. <U>Entire Agreement</U>. This Agreement (including the Plan and the Employee Grant Details), together with the Offer Letter
provisions regarding Recipient&#146;s inducement awards, contains the entire understanding between the parties and supersedes any prior understanding and agreements between them regarding the subject matter hereof with respect to this Award, and
there are no other representations, agreements, arrangements or understandings, oral or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
written, between the parties relating to this Award which are not fully expressed herein. Notwithstanding anything to the contrary set forth in this Agreement, any restrictive covenants contained
in this Agreement are independent, and are not intended to limit the enforceability, of any restrictive or other covenants contained in any other agreement between the Company and the Recipient. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">21. <U>Captions; Section</U><U></U><U>&nbsp;References</U>. Section&nbsp;and other headings contained in this Agreement are for
reference purposes only and are in no way intended to describe, interpret, define or limit the scope, extent or intent of this Agreement or any provision hereof. Unless expressly provided otherwise, any reference in this Agreement to any
Section&nbsp;refers to the corresponding Section&nbsp;of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">22. <U>Limitation of Actions</U>. Any lawsuit
commenced by the Recipient with respect to any matter arising out of or relating to this Agreement must be filed no later than one (1)&nbsp;year after the date that a denial of any claim hereunder is made or any earlier date that the claim otherwise
accrues. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">23. <U>Section</U><U></U><U>&nbsp;409A</U>. This Agreement and this Award are intended to satisfy all applicable
requirements of Section&nbsp;409A or an exception thereto and shall be construed accordingly. Coherent may in its sole discretion, and without the consent of the Recipient, take any action it deems necessary to comply with the requirements of
Section&nbsp;409A or an exception thereto, including amending the terms of this Award and this Agreement, in any manner it deems necessary to cause this Award and this Agreement to be excepted from Section&nbsp;409A (or to comply therewith to the
extent that Coherent determines that it is not excepted). Notwithstanding, the Recipient recognizes and acknowledges that Section&nbsp;409A may affect the timing and recognition of payments due hereunder, and may impose upon the Recipient certain
taxes or other charges for which the Recipient is and shall remain solely responsible. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">24. <U>Assignment</U>. Except as
provided in <U>Section</U><U></U><U>&nbsp;6</U>, the Recipient&#146;s rights and obligations under this Agreement shall not be transferable by the Recipient, by assignment or otherwise, and any purported assignment, transfer or delegation thereof by
the Recipient shall be void. Coherent may assign/delegate all or any portion of this Agreement and its rights hereunder without prior notice to the Recipient and without the Recipient providing any additional consent thereto, whereupon the Recipient
shall continue to be bound hereby with respect to such assignee/delegatee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">25. <U>Electronic Delivery</U>. Coherent may,
in its sole discretion, deliver any documents or correspondence related to this Agreement, the Units, the Plan, the Recipient&#146;s participation in the Plan or future awards that may be granted to the Recipient under the Plan, by electronic means.
The Recipient hereby consents to receive such documents by electronic delivery and to the Recipient&#146;s participation in the Plan through an <FONT STYLE="white-space:nowrap">on-line</FONT> or electronic system established and maintained by
Coherent or another third party designated by Coherent, including the Solium </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Shareworks System. Likewise, Coherent may require the Recipient to deliver or receive any documents or correspondence related to this Agreement by such electronic means. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">26. <U>Further Assurances</U>. The Company and the Recipient shall use commercially reasonable efforts to, from time to time at
the request of the other party, without any additional consideration, furnish the other party such further information or assurances, execute and deliver such additional documents and take such other actions and do such other things, as may be
necessary to carry out the provisions of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">27. <U>Compliance with Legal Requirements</U>. Notwithstanding
any other provisions of the Plan or this Agreement, unless there is an exemption from any registration, qualification or other legal requirement applicable to the Shares, the Company shall not be required to deliver any Shares issuable upon vesting
of this Award prior to the completion of any registration or qualification of the Shares under any local, state, federal or foreign securities or exchange control law or under rulings or regulations of the U.S. Securities and Exchange Commission
(&#147;<I>SEC</I>&#148;) or of any other governmental regulatory body, or prior to obtaining any approval or other clearance from any local, state, federal or foreign governmental agency, which registration, qualification or approval the Company
shall, in its absolute discretion, deem necessary or advisable. Further, the Company is under no obligation to register or qualify the Shares with the SEC or any state or foreign securities commission or to seek approval or clearance from any
governmental authority for the issuance or sale of Shares. Subject to Section&nbsp;409A, the Committee may postpone the issuance or delivery of Shares under this Award as the Committee may consider appropriate and may require the Recipient to make
such representations and furnish such information as it may consider appropriate in connection with the issuance or delivery of Shares in compliance with applicable laws, rules and regulations. The Recipient understands and agrees that the Company
shall have unilateral authority to amend this Agreement without his or her consent to the extent necessary to comply with securities or other laws applicable to the issuance of Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">28. <U>Imposition of Other Requirements</U>. The Company reserves the right to impose other requirements on this Award to the
extent that the Company determines that it is necessary or advisable in order to comply with local law or facilitate the administration of this Award and to require the Recipient to sign any additional agreements or undertakings that may be
necessary to accomplish the foregoing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">29. <U>No Advice Regarding Grant</U>. The Company is not providing any tax, legal
or financial advice, nor is the Company making any recommendations regarding the Recipient&#146;s participation in the Plan or the Recipient&#146;s acquisition or sale of Shares. The Recipient understands and agrees that the Recipient should consult
with his or her own personal legal and financial advisors regarding the Recipient&#146;s participation in the Plan before taking any action related to the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">30. <U>Amendments</U>. This Agreement may be amended or modified at any time by an instrument in writing signed by the parties
hereto, or as otherwise provided under the Plan or this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGE FOLLOWS] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">IN WITNESS WHEREOF, the parties have executed this Agreement as of the Grant
Date set forth above. Electronic acceptance of this Agreement by the Recipient pursuant to Coherent&#146;s instructions to the Recipient (including through the Solium Shareworks System) shall constitute execution of this Agreement by the Recipient.
The Recipient agrees that his or her electronic acceptance of this Agreement, including via the Solium Shareworks System, shall constitute his or her signature, and that he or she agrees to be bound by all of the terms and conditions of this
Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">COHERENT CORP.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&nbsp;&#8195;&#8195;&#8195;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Chiew Mee Yong</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Chief Human Resources Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">RECIPIENT</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Electronic Acceptance via the</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Solium Shareworks System</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Coherent Corp. Inducement Award (Performance Share Units) </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>d845190dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g845190g0601051447740.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Coherent Corp.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">375 Saxonburg Blvd.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Saxonburg, PA 16056-9499</P></TD></TR>
</TABLE> <P STYLE="margin-top:30pt; margin-bottom:0pt; margin-left:6%; font-size:14pt; font-family:ARIAL"><B>PRESS RELEASE </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; margin-left:6%; font-size:18pt; font-family:ARIAL"><B>COHERENT APPOINTS JIM ANDERSON AS CHIEF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:6%; font-size:18pt; font-family:ARIAL"><B>EXECUTIVE OFFICER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL" ALIGN="justify">PITTSBURGH, June&nbsp;3, 2024 (GLOBE NEWSWIRE) &#150; Coherent Corp. (the &#147;Company&#148; or &#147;Coherent&#148;) (NYSE: COHR), a
global leader in materials, networking, and lasers, today announced that following a comprehensive search, its Board of Directors has appointed Jim Anderson, an established industry executive with a proven track record of driving innovation and
leading business transformations, as the Company&#146;s new Chief Executive Officer, effective today. Mr.&nbsp;Anderson also joins the Company&#146;s Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL" ALIGN="justify">Mr.&nbsp;Anderson joins Coherent from Lattice Semiconductors (&#147;Lattice&#148;), where he was President, Chief Executive Officer, and
a member of its Board of Directors. As CEO, Mr.&nbsp;Anderson was responsible for driving Lattice&#146;s corporate strategy and strengthening the Company&#146;s product roadmap, achieving record operating profits and gross margins. He succeeds
Dr.&nbsp;Vincent&nbsp;D. (&#147;Chuck&#148;) Mattera, Jr., who, as previously announced, is retiring as Chair and CEO of Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL" ALIGN="justify">&#147;Jim&#146;s business acumen and technical capability, coupled with his extensive experience transforming complex global businesses
to deliver above-market growth and profitability, make him the ideal leader to steer Coherent through its next chapter amidst a rapidly changing market,&#148; said Enrico DiGirolamo, the Board Chair. &#147;I am confident that Coherent will benefit
from Jim&#146;s operational expertise, innovation-first approach, and <FONT STYLE="white-space:nowrap">in-depth</FONT> knowledge of our market and platform, as we capitalize on the strong market demand we see across our <FONT
STYLE="white-space:nowrap">AI-related</FONT> datacom portfolio and improving industrial market, while leveraging our diversification strategy that continues to serve us well.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL" ALIGN="justify">&#147;I am deeply honored to join Coherent, a company I have long admired, as its next CEO,&#148; said Mr.&nbsp;Anderson. &#147;With
cutting-edge innovation, an industry-leading platform, and an intense focus on the customer, Coherent is exceptionally well positioned to build on its existing momentum and deliver enhanced profitable growth over the long term. I look forward to
joining the leadership team and Board at this pivotal moment in the Company&#146;s history as we work together to realize Coherent&#146;s enormous potential and drive value for all stakeholders.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL" ALIGN="justify">&#147;Chuck Mattera has been in and around this industry for almost half a century, conceptualizing and directing the acquisition and
business development strategy that made Coherent the multi-billion dollar global entity it is today&#148;, said Mr.&nbsp;DiGirolamo. &#147;Chuck thoughtfully forged meaningful relationships with employees, customers, suppliers, government officials,
key partners, and shareholders that established a values-based foundation.&#148; DiGirolamo added, &#147;On behalf of the Board, I have the privilege of thanking Chuck for his many years of visionary leadership, tireless execution, and energetic
commitment to redefining the possibilities of our industry. We all look forward to learning about the next chapters of Chuck&#146;s already accomplished story&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">coherent.com&#8195;&#8194; I&#8195;&#8194; T. 724 352 4455</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL"><I>About Jim Anderson </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL" ALIGN="justify">Prior to joining Lattice in 2018, Mr.&nbsp;Anderson was senior vice president and general manager of Advanced Micro Devices&#146;
Computing and Graphics business group. He previously held leadership positions in general management, engineering, sales, marketing, and strategy at companies including, Intel, Broadcom (formerly Avago Technologies), and LSI Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL" ALIGN="justify">Mr.&nbsp;Anderson serves on the Board of Directors of Entegris, EdgeQ, and Lumotive, as well as on the Board of Directors of the
Semiconductor Industry Association, the MIT Sloan Americas Executive Board, the Electrical and Computer Engineering Advisory Board at Purdue University, and the Dean&#146;s Advisory Board for the College of Science and Engineering at the University
of Minnesota. Previously, he was a director at Sierra Wireless. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL" ALIGN="justify">Mr.&nbsp;Anderson holds an MBA and Master of Science in electrical
engineering and computer science from the Massachusetts Institute of Technology, a Master of Science in electrical engineering from Purdue University, and a Bachelor&#146;s degree in electrical engineering from the University of Minnesota. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL"><I>About Coherent </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL" ALIGN="justify">Coherent
empowers market innovators to define the future through breakthrough technologies, from materials to systems. We deliver innovations that resonate with our customers in diversified applications for the industrial, communications, electronics, and
instrumentation markets. Headquartered in Saxonburg, Pennsylvania, Coherent has research and development, manufacturing, sales, service, and distribution facilities worldwide. For more information, please visit us at coherent.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL"><B>Contact: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL">Amy Wilson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL">Manager, Corporate Communications &amp; Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL">corporate.communications@coherent.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL"><B>Media
Contact: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL">Samantha Gaspar </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL">Teneo </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL"><FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0563c1"><U>Samantha.gaspar@teneo.com</U></FONT><FONT STYLE="font-family:ARIAL"> </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL"><B>Forward Looking Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL" ALIGN="justify">The statements contained in this press release include forward-looking statements relating to future events and expectations, including
statements regarding the Company&#146;s ability (i)&nbsp;to benefit from Mr.&nbsp;Anderson&#146;s operational expertise, innovation-first approach, and <FONT STYLE="white-space:nowrap">in-depth</FONT> knowledge of our market and platform; and
(ii)&nbsp;to build on its existing momentum, to deliver enhanced profitable growth over the long term, and to realize on our enormous potential and drive value for all stakeholders, each of which is based on certain assumptions and contingencies.
The forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and relate to the Company&#146;s performance on a going-forward basis. The forward-looking statements
contained herein involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="right">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:6%; font-size:11pt; font-family:ARIAL" ALIGN="justify">The Company believes that all forward-looking statements made by it herein have a
reasonable basis, but there can be no assurance that management&#146;s expectations, beliefs, or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and global
economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements herein include but are not limited to: (i)&nbsp;the failure of any one or more of the assumptions stated herein
to prove to be correct; (ii)&nbsp;the risks relating to forward-looking statements and other &#147;Risk Factors&#148; discussed in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended
June&nbsp;30, 2023, and additional risk factors that may be identified from time to time in filings of the Company; (iii)&nbsp;the substantial indebtedness the Company incurred in connection with its acquisition (the &#147;Transaction&#148;) of
Coherent, Inc. (&#147;Coherent&#148;), the need to generate sufficient cash flows to service and repay such debt, and the Company&#146;s ability to generate sufficient funds to meet its anticipated debt reduction goals; (iv)&nbsp;the possibility
that the Company may not be able to continue its integration progress and/or take other restructuring actions, or otherwise be able to achieve expected synergies, operating efficiencies including greater scale, focus, resiliency, and lower operating
costs, and other benefits within the expected time frames or at all and ultimately to successfully fully integrate the operations of Coherent with those of the Company; (v)&nbsp;the possibility that such integration and/or the restructuring actions
may be more difficult, time-consuming, or costly than expected or that operating costs and business disruption (including, without limitation, disruptions in relationships with employees, customers, or suppliers) may be greater than expected in
connection with the Transaction and/or the restructuring actions; (vi)&nbsp;any unexpected costs, charges, or expenses resulting from the Transaction and/or the restructuring actions; (vii)&nbsp;the risk that disruption from the Transaction and/or
the restructuring actions materially and adversely affects the respective businesses and operations of the Company and Coherent; (viii)&nbsp;potential adverse reactions or changes to business relationships resulting from the completion of the
Transaction and/or the restructuring actions; (ix)&nbsp;the ability of the Company to retain and hire key employees; (x)&nbsp;the purchasing patterns of customers and end users; (xi)&nbsp;the timely release of new products and acceptance of such new
products by the market; (xii)&nbsp;the introduction of new products by competitors and other competitive responses; (xiii)&nbsp;the Company&#146;s ability to assimilate other recently acquired businesses, and realize synergies, cost savings, and
opportunities for growth in connection therewith, together with the risks, costs, and uncertainties associated with such acquisitions; (xiv)&nbsp;the Company&#146;s ability to devise and execute strategies to respond to market conditions;
(xv)&nbsp;the risks to realizing the benefits of investments in R&amp;D and commercialization of innovations; (xvi)&nbsp;the risks that the Company&#146;s stock price will not trade in line with industrial technology leaders; and/or (xvii)&nbsp;the
risks of business and economic disruption related to worldwide health epidemics or outbreaks that may arise. The Company disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new
information, future events or developments, or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="right">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cohr-20240602.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/3/2024 4:01:56 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:cohr="http://imetrix.edgar-online.com/20240602"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://imetrix.edgar-online.com/20240602"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cohr-20240602_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cohr-20240602_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>cohr-20240602_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/3/2024 4:01:56 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>cohr-20240602_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/3/2024 4:01:56 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cohr-20240602.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g845190dsp_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g845190dsp_5.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M;)&!U(KZ;-<)4QF&=*GO=;G#AZBISYF>R:7\6/#VK:I:Z?;17HFN9!&A>)0
M3Z_-7QM?(<50IRJR:LE??_@'IPQ=.4E%7-'XC_\ )/=8_P"N0_\ 0UKGR?\
MWZGZ_HR\3_"D?-UM8375I>7$0RMHBO(/]DL%S^9%?I,ZL82C%_:_RN>(HMIM
M=#T"/6_[3^!]Y8R-F;3[B./WV%\K_4?A7SSPWL<XC46TDW\[:G8I\V&<>QI_
M K_C[UO_ '(OYM7-Q/\ #2^?Z%X#>1Z5XT_Y$C6_^O.7_P!!-?-9;_OE+_$O
MS.^O_#EZ'A'PM_Y*+I?_ &T_]%M7W>>?[A4^7YH\C"_QD?2E?FI[AX[\=_\
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M"XG"RI4V[NW3S."AAJE.HI,]EKXP],* "@ H * "@ H * "@ H * "@ H *
="@ H * "@ H * "@ H * "@ H * "@ H * /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g845190g0601051447740.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g845190g0601051447740.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J -D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P"+Q]\0-4UG
M6[C3].NI;?3H)#$BPL5,Q!P6)')!/0=,8[USU[X=\4>&X(]4N;2\L5=@%G#X
M()]<'*GZXJGX;^?Q5I(;G=>PYSW^<5](>.M-N-7\%ZE8VD'GW$J+Y<8(&2&!
M[_2OT#$XJ&5SHX6G!<LMV_NO^NIX].F\0I5&]4<O\*O'%UXB@GTO4Y/-OK9!
M)',>LD><'/N"1SWS78>)?$VG^%=*:^OW//RQ1+]Z5O0?X]J\P^&7@[Q%H7B]
M;S4=-DM[8P.C.74C)Q@<'U%4K[5+?Q;XWUC5+]/M.EZ):R26]KGY9=A"J#[,
MQR?; KQ\1EV&K8^4J3O323?+;=Z67J_N.F%:<:*4OBVU_,Q=?^(_B?Q#(YAF
MELK//$-H2N!_M,.3_+VJ5?"^D0S6MCKNN75OK]XBNN$#16Q;E%E8G.3QTZ9Y
M]:M^%/&GB37/&.EV OQ;6<DXS;6T2QQK&/F*@ =, U3O_'5GK.IW0U_1+2^M
M7E;RYX5\FXC7/RX<?>P,<'TKW53K4Y>QHTU!)7?*TWKHMTD]G?77OWY+QDN:
M3OZ_\ HVWBKQ7X-U::R_M"</;2%)+>=C)&<>Q['U&*]J\$>/K'QA;M$5%MJ,
M2YEMR<AA_>4]Q^H_6O%M4\,0RVO]MZ1?RZCHZE5G8KFXM1TPZ9].A''':I8]
M+;P^L?BCPUK4.HPV,J>=B-HI(MW #H?X3RN0:QQ^"PF-I*VE3:]FM>TNU^E]
M>Q5&K4I2[K]/(]9^+=S/:^!VEMYI(9!<QC=&Y4]^XKDO@M?WEYK6IK=7<\ZK
M;J0))"P'S>];OQ.U"'5OA=;ZA!_JKF2&50>V03CZBN9^!O\ R&]4_P"O9?\
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M4CB::K/XHWB_O7Z)'%B(N#Y>CLS[ M?^/2'_ *YK_*O!/C3_ ,CO%_UY1_\
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M!-A9VE]=-;6D$+-& 3'&%)&?:EAJULFJ4[;O_(=2/^U19ROQU_X]]#_WI_\
MV2K_ ,#_ /D6=1_Z_/\ V1:Z/QQ96EXEC]JM89]A?;YL8;&=N<9J?P5:6UII
MMPEM;Q0J9LD1H%!.!Z43K?\ ")&G;K_[<P4?]J;_ *V/G'5I#%XCO9  2EV[
M 'V<UZ!_PO#6O^@78?\ C_\ \56[>:-I;7UPS:;9EC(Q),"Y//TJ'^Q=*_Z!
MEE_X#K_A7T-58?$PC[:GS66FIQ1YX-\LK&Y\//']_P",;Z]M[NTMH%@B#J8M
MV22<<Y)KQ'1/^1NT[_K^B_\ 0Q7O7@FPL[2\NFMK2"%FC )BC"DC/M6#9:/I
M::K;NFFV:LLZD$0*"#N'M7!A94\/7Q$:4+)J.GR9M44IP@Y/74ZGXC:3_;'@
M;4HE7,L*?:(_JG)_,9'XUY'\(=8_LWQHMH[8BOXS"<]-X^93^A'_  *OH210
MT3JP!4J001P:\NTW2--BU6SDCTZT1UG0JRP*"#N'(.*\[**W/@:V'DKK_-?\
M WQ,;58S1Q/Q?_Y'^X_ZX1?^@U+H?Q:U70M%M=,@T^SDBMTV*S[LGG/.#[UZ
M'XMTRPN=>DEN+&VED*+EY(E8GCU(K#_L72O^@99?^ Z_X5[.'=&O@J5.M#F2
M2Z^1RSYH592B[#O"OQ9U77_$]CI<^GV<<5PY5G3=N'!/&3[5Q_Q<_P"2A7?_
M %RB_P#0!7H/AW2M.@U^SEAL+6.17)5TA4$<'N!4_BS3+"Y\032SV-M+(57+
MR1*Q/'J17/0]CALQ7L867)M?S+GS3H>\[Z_H=/IEE%J7@6RL9QF*XTV.)_H8
MP*^7]0LI=-U&YLIQB:WE:)Q[@XKZSTY%CTRT1%"HL*!548 &T<"N \2:3ILW
MB"[DET^T>1F!9FA4DG:.IQ7%D.,E2Q%6%KIZ_C_P37&4U*$6>AVO_'I#_P!<
MU_E7@GQI_P"1WB_Z\H__ $)Z]]B $2 # "BN%\9:=8W6M+)<V5O,_DJ-TD2L
M<9/<BN'(:OL\;S6Z,UQD;TK%OX5_\DZTOZR_^C&KLJQ_"\$-MX>MHH(DBC7=
<A(U"@?,>PK8KSL?+FQ51_P!Y_F;T5:G%>2/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140462187523280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 02, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000820318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  02,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Coherent Corp.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">25-1214948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">375 Saxonburg Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Saxonburg<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">16056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(724)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">352-4455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">COHR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ @$##6)>*NQS     $P(   L
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MEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( (!
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( (! PU@)1@L:/ 0  '\0   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " " 0,-8GZ ;\+$"  #B#   #0              @ & #   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( (! PUB7BKL<P    !,"   +
M  "  5P/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( (! PU@<.&7J/P$  #P"
M   /              "  440  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" " 0,-8)!Z;HJT   #X 0  &@              @ &Q$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " " 0,-899!YDAD!  #/ P
M$P              @ &6$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  #@$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d845190d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cohr-20240602.xsd</File>
    <File>cohr-20240602_lab.xml</File>
    <File>cohr-20240602_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d845190d8k.htm">d845190d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d845190d8k.htm": {
   "nsprefix": "cohr",
   "nsuri": "http://imetrix.edgar-online.com/20240602",
   "dts": {
    "schema": {
     "local": [
      "cohr-20240602.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cohr-20240602_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cohr-20240602_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d845190d8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-06-02_to_2024-06-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d845190d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-06-02_to_2024-06-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d845190d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://imetrix.edgar-online.com//20240602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-24-152389-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-152389-xbrl.zip
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MIQ.AC;/4?^@O7V]A>.2JA-8<#.R=LFTCV_8;B^7?ZBR<"RZ+1FZ2WX$[C7W
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MTW4LBZ/F,'#G\!UL2N_X_P%02P,$%     @ @$##6+.-^RG47   L/@! !$
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ML6D[X&+[(S@27/D9)YQX'N%"(S!U2:7)Z=A&;+0(&55X7>+,C!CN2;/Z.A#
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ML!9T??,YK3@RR'FUGHN:IB;)O9S3B)IZBBF^ ;G[XO%/N,P47\0>/<BIV&I
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MS35N\,[C3OQ)/_H2XD]U _G,_;+Z@4#H<" 1<ROY+\JS;-#$K'@EY G*,<R
M#2I]/-ZV*Z?VVO,0+\U03$PX<Y@%CR1GH;],;Z"U3-=%CE]=Y/AX98L<_3K7
M*MI]O/V*&.W])T^>K)WHM\]5'Z^N!WTOP;_$EBE:W9GV\CDG%Y*"[:M=JJ!Q
M:BO61!0ULA1M.$I6W4:LV5@U:@J1#R6ON18>@H?-947M8M'2I90F&\!T@!\V
M>Y*@5C'+41J3^4.*OU__Y"*G0*EDV]:V O66ZON#-J,-?)2+.'2SN'YCTWD
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M'._JUF.!/V^@W)8BD8(4Z3F0Z&/?B^3S2>OPDQ*%93"A_1YO2SH6Y.(1%YZ
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MA*_RH5X= UJ*>$]U,^=I0-SP\#FWG&1:&V-1^BJI!@LI# L*0JP-;]I/JK#
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M>5ID&42;J:R&/;%JN1]*.(Q@<<@S<#FVV!^CK[PMEG7W5E]8Q;P$O=5<.\5
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MC#Z&.2>7^Q8&WGO\?$5VO:6L95<$55Q;>I\PKHN%5:&DU_"A<32"C2JF1C.
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M[]&3>>]R3R;(K7<O/\*'KT]_>?/B_P-02P,$%     @ @$##6*AWE'8<-P
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MYC8D]0SD^B 2QQ_SR0@H)K K5UD]1S*3)UBZQ'7/NL.39?&E@H^,>W>TWOH
MQ% Q9@I:^)D>L6\F[(I>G>IJ &R096S79'-.^2S%OZ["+-1C>L?JRK7Z&,!H
M\) D# KU/*1<HQX&]6M2.H<Z*VZC?^NRV$ >8Y!/R%ES*A4P&<V7?DM\Q3L
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M!-6%[?'?G^;#G5'R$>CUVMYP(L+&70[0R30TJ<@NYNN%,F.31J\Y;"S"LMW
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M4E5V&7,*1F:$3**/I!?W7L'D/,G.X1-NKUD2&DKF3O"5@/ L(H '< .QNGE
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M^:U6&5](&/"'05K!4J.6O#P'<UN<:6[&E2GHMJ8@K&>9*TQL7U(G43H13)*
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MJ9#("H, O2%L<2,&G.OE7629UA0#J\)4@';K^<\^E4$ZO(+?N[L-PW[#7DI
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M_:^:AMT1*HK3',.;UT5>SVD<K<#B>9%?%VJ&,) *7;EEI21$32[=0E_G\&F
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M@T;HIF"_AYA;6#!8*<8/>>L%FAR,:1>6R#S +M0"!.@GO Y34F)53I%61):
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MS716RI-0!N9E94Z455EI7X9+1L0EYP7ELJ+3,8N.0-53^&]2Q/4,3PN0Z,Q
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MC%(N 3N/K4MF2&-TM1R,>6%Q=ZW3>J0SX( JVKB=:K+WR)V/"" )*?EO8^O
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M,U91FB!7XBY3EFW80/(6L>%3L^'O!L7P?C(MN9R9+*KBTUH!)U>>Z@",A)"
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M.SZ/P)3)5) ]\3VZN9[^<'-]MVZNSQX7_V.:I,TC+?$2VYN^8.<I2!!O[Q]
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M:)/Y+(E!Y:!6>=QSR,\N-/=OLF.,'BWY 7>KCVP&&2HR_#HYJZ^3B3F!)]_
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M<-$EXCIS=3/@2O\7<A_Z^7?]7L/**; HL2@\JQI7?7VUXYF$S\-J\Z>@%:7
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MQTD M#!^E*4ZPLPE;S8BL9)%R(>25,KQ*@>6Z$M:^MXE=;C73+2C"TBC1?1
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M%YC)*AG+]Y(DP=3^3I2]&!Z=G)^ ./Y!OD\AGZ?J'CH-3Y2XO]LN7::SAG1
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MR4T!ZQ<P,?PSF;'1XX/*)M!61N_<HS68'C$N"B/C5.8@.P)#?$(PQ%QA0WJ
MM6-B@C:>% :&YW0%'C[BW"J*E(KMZLI18.0WG1$N=!^.ND&TA],JN@X^?0H^
M< #B2-$E*1NV7CC@C3:531J>"A\D<92Z8#^%U*92%TP-Y$="#?K]88;G^$,4
M".*M751&5:K8?Y&GHVFF(\2M2.9RI!-=SMI08)4GB!(<$J;@%-G<AR#U!2K0
M"C*8>SJ)@ )5HKX('P7#60HJ*(V(58*7(9\1@DL'S%VKDM1V2R$'9#AMUN>G
M\AKFC?A%1@+;GH=5[&5+A3]J]RFGA:DF4[;H#'2*:"KSDLY*=6Q+1+1"YCJ&
M\O!%-B%:W?EM'^&M!*CN9P7\#IYPK N3R!2:I[.=B[!NNSX/#+ QN,W&[',N
M8M?$W.H$O*M,@9O5%?;LA@*\]9H,_+ <2VU5NQ%2.V-=$,DYY"$IT)-L]CZ<
M(_V' G*J2]6QN8S43F9NP5IK'W82J[R<[JW1RGUQC2^@O8DB,S15X?EU@DYD
M22ICP[Y5I'7(/8%A"?@XL0PO-;6,H+B47KNEW*-@..QIM*>C:G7E$;IZ@TZA
M<)Z* V6Q+"4,12 Z@(I$&Z9)IY1S7'+AK(2<&70$)]0(-HF"]4A6'AT>DS%9
MC>#F,E$=9E@;4 Y"1*4L6XLJ8+45,9LD7:_R'^J1;$"Q4CE,<FHR4U#>=[FL
M-J2V3_T(CF* O X6$M(*XB)B=<S:JPV> G;3EN_$[F"ZG^'.JRO(#11!.VPA
M<]MCB!!@02>D]8:]0%.\@B(!A?\(0O4V@S\A)THTM2=PT(A@EFSN8)7D#\5;
M34\<RZ-*)S'M0:RH+]IR9$^Q4U96*9\8 H?*X+R$D$*D@%'X^&'H>Z*")03/
M3[N066+,->6H6W+@TJRND'Q#WG'!Q$YUCO72G>1<79)'@_9<WYB2S)")(31W
M3[["0F3-F7<E G@X::*PD@,52G=VK"9RI-<4=)XBGT :D&5)ULZL%A1?;V12
MN>0*J<&P$0FG)B%J_Q+&R^DRY$D&G".ER"J<?2 44U(A"=8(T_&2&@2VJ4S&
M9-FDWX+S3$8F4I&<.(^2&!B,!$W)Z)^5=C;C0$R=Q&*$A,3DK)Y%_T^AW&9^
M4"*MDE)WD%T2VB<&OI9%R%2D@7(&$R239;CIY-Q><J9Y:@CNY&113BG]E..*
MC!R\3F"DJ9)D:W@F. (2$(:Q69=0%3*EF2D%;!P<!W_:*L\3S7].R*0SYLP0
M@N,:8G7E6LU$+HLRXT6,J*:R".;A>&]B?.F,R79&J#9BT ;=,"W!DN8L(;#$
M%%8<8^<9M,JZ0@*ITV [1")ZDA/R2Y3+,3@YH]I&.(F0PLD"4HI>,Y0LEA;=
M0(T(!3"(N?<AR4+;":G3UR$N#L70BH(D 2H1KTR:ZI*EP4X5([G6GHR  CA*
ML$$K&_)=,+VN^*S8C9:" 5%0\!; (Y4SD29TX(UJ8$@N*Q,X<PQ/CQCG./FR
M\SM1.I GJ(F;/U!]W_%*T73#M_\5[=0'FJG;&_]F+W3K[4(O]-OT03<>ZX,N
M1;=G]46_HOT:!? /<_GEI[<;[[9W^9^M73%8^GS5%6]>;8G-[5=B:VM[^^MZ
MHH^W-Y<Z_QMSR=9M,V[8KAT-?L,C/Z=@W=%N.2Q[EJC%S$+]NR59T*.&<D8*
M'@;E)+=R9DG*:SGEJ8]0Y.!_(=O-5MB7YR@[/[WC_Y9,V)-^V#^[ZE]^ETG*
M\W/C_MY@O\>1H]EC <.#']8#*[0I HIL5.24F%^M;[Q]J*"WJ,7QX@TMS4,?
MP=74%($9AV=0,?<,>O&-PV"G&G6 .%+TFG4A<G6%L%%5ABQ^C I@JJ-&T0FT
M5N5<G#?JZ:D" &R@L8 /"3XLD9 R+%94P:'^XTZ:E0DE45<JU+VU><^A]!B:
M4@.J_Z2*>=$ QI2TQ0&U&:@:>4$ 5Q4@IW<C)T9<44UL$C/!>R_=GB?# 3<*
MC:O?_D+-)*YO:B!^3U,0'_I@>%)HB*H/S/]WSU*5&FH2^4H065(^L0V^0;W7
M;%!!E![D]:PUP"DN@=,6IP/4K(E!Q="#;%&HV49?RN,)6M=/<$#!'0ANGK 5
MP=[Z<T63X6E+0+O&Z!=5$0,F?\I<(4@] ^YF8,,C8*^0MI=>)&#B8'P2H,LP
M<KT,>KMYI'2H8'[ Z@I6GZ)<4A:%09>Z;MZ(VZ$1)SUV);Q;BB&P'"#R9P]P
M/$+X"U@,X47JFXG3@Q[S?2IMZ3P\2 /.IVJ]K*ZHIF#P0A249/UZ;G2PUJ6U
M,II65I4HZ089B"BQDO:NO8IT]=2933]WNS^@<2D.<!X*@2+H/(:IJR>W6U2N
M6-3M]W'N>1:I:Y600;Z_F002H.PT-[>$@7T'R'<(* 9P(P_@VY4 XPI%G*K[
M;PP"PH>R$4+;3N+U-(2[,C.H/[4,T$.)/V]%^%H&^0@%0^DG$P3LZW*)U%LW
M@:C4H=HI\B\'-Y]WDZC23-,J"TO:WC8,GEC?'0>V+ OJBY:NI^38YW:RC/]9
MH>Y2!0].1'-&J;+,SA+D12T;S8^IZY7SM,:W,>IBE?)55HUE!.DULQ@%<N33
MMB^"B? 1%T0":T.!<VN*) ;T45WQ 5RF %R@J)ZVM$6.9&H5%ULE=;TX!\ZQ
MZ/>S[0.8%$09E3OWW33YS\"R7CI#O$T<%ON6H]"'#CQUX*A=8P-N$34,3?PB
MTQR8/T..IKQP&;H!WXG >A+3772 OS6-XOMD)C*)4Q5K25#Q>UO&4,+I$%3$
ML;2Y+![A^!L>>@7\:KZ3HA>&!$_7Q<)?9?MI??OU9K2!]S_5,NI.6$9_*XE\
MLH^]M4_[OH/_^#%<]+EUWRW*?/!=G1-CN 4U1/CF6L'^R#L)5SQ(J2FAB834
MF4L?KK]<4$U$T)#"M2M.5&A1=1+/3&,+UT>DKI<)F1<Y)?,34)HF165(;G6M
ML[JRL,,$>S\P>O6C-_%"OW1PD=KS;H[ETO<='/D7'&KMNDS^0C>9>'3&T!:-
MX>2S9@R^X)AW^7$$D?4GF_M )) -\09AX ^8B.O:8ML(,I748;>V2G.7/AP,
MISD7JF0@:-M=72&C>\2")$R&6^-Y5=A*NG8J3_SD6 &R%"/0Q9,XRT?XWN^G
M[I"J'7U#V6V("JYP4.0$_TP<5+JDSD\J>A'UJ\7&NW?;3)\;_H53EF?]JF#8
M0M"?>OMB8F@H%9JT8%X#>SW.$O6&@V-1.M,TB+@Q"22-:O?:28G&]2R_DK&H
M$V]D*EA%)%&H"$)BDAKUMDI*K&A0UJ;K/W1K(7;@5X_'JJB1+/7[72UA+ _&
MR:>#CS^J"D^LX6M"H1U"H"]*C(5KWW-;9>ENKG@RC2RUD[]58_K/7E)^(G+Z
M5N6KT$?__^[DMTU&WOL0TQ.MJ&'$%19%H4?,E*/%B&=CWF)Y_@,$!Y%2;481
MDCVUC3C+'9."KA30^$ADA@-6P1[NYW*ACU=/0A?2%M,VMNQTB$-_T!B08YU]
MEG/Q'0SGU/!0$R%B^1WY/AG1!EA,C9HN@#E-OMQX$5^%CF,]N^1.*,\)41@C
MV)A41Q1WW2M4VDK7'O,7#QZ**D]&#_+]ZGG1(X &DCS%]LR4(M&I+GFXOM-(
MY;2=U EA!L1G,@.#&C[4CS[.-[,+'Q9B*E_@N4=ZNZ*1:*<AY"[@E$>2$01K
M>%#N1HZ7>%E\<,+TT\D[(EG*(+TL(PE?*KI-0CGD R6A)X'%QGKG?P*H")V"
M,8["5C2K1 */%4!$XR;I.E\EW?0-)V\NI%NB><$ 4DD>)KB+[AH33L4Z=6F0
M_@4S8V"M;%)G6,\7R[,I4%N-(#&'(>@J]0@Z<5<L&PX-*Z@*WYB 86;.:5S+
MA._'-0;HC4NN5W1W2_+:</G-C*DR"_=/!EDTOR.W>/6U[0>F[A*'\QFZZU?Q
MK)KZ'Y&T4S%.S&U]!4?['FNA<LC(5LC!Q-"\;?L 'GW@@''E4W*JJ$7%!E7B
MNYSMEG:F07'E9#$Q,K$DW9N&<.>#XQD,?.K[O4&JI$CR)RB3@QQ."K>*^#3-
M'76'?N :$T;S8&6-#(HNKSG;QN.RJ'RG1SAQN_C&W]\"*3>/<-<=E0^+-&&>
MT1B<<<O\YJ/R4H@6QAI JDJZGJQ, %SX?DZ;* "/6.S[I0GU]N:;$8*RI;]-
MX&CVJ-_=5?">5Q/$%CPN9$HC!VYS4PIAF)7@.Q"0L,[X_J6U_E($_S^(S#4/
MZZK!-N]*.K-U$?&.<SR@/>=Y;%%-K01E4&"Z3PNK*]Y9.092;-81>&@SBQTH
M&]&0VW/8A&24\$'97!2\.4Z>*X9%R<*87U+1MJARYWR-"12Q28U?#M>^<S=?
MRMW-K[XW CKJJR,O0P0*QK!(,L7RY1A! FH$@R?E1HH(08H\!6$R;.]-*4(I
M,5&.,OHNL\KZ/+C0?G_VJ<O)QLF_(>)'MB8??V#O9D9V$9[ZRF3(DJ^AVT!6
M[N^DS^^V.K=9,.5F%'$#+6?:CH/ 0J,X=*=1&>G)(8.CFZKN_F)M2HL&<8\\
MW0U<YCD,ZYXI8OVE(>$0@9=XXHK7E:/@;JKA/'0OJ;9-;-/<!;4FF+%\E9 O
MC3DIS1OY[K(/X@?](()>;FJ9?!%Z"&T2O$@_&_#7Q-V[,J(;9*Z,'+LP@#6K
M*_6BT<Q= >-V 1_0/ $APRWT8EO8'Z^24"%33O'S&!F>DC7X._&.\\4$_G!.
M ]B"ZW-Y'#(%W;(AFZ-\3?E\;F5MGSE=GZ&1$\CA4+W3U=DPQ3 YH:$J<S4Z
MX1O?P5B$!XS4R?_;\QN+=3A@(-<6C<RP4$,3\3SK#1?$6>@-G.$D<?-5@HA1
M^UKE>U@T'JY_,Z"=_3OQ,M+P'9\Y_-Y=77GQY>8.!*V;,J'75:<T^N$#M^(=
M"(5,+KE!?Q3&FC!)NFVG_R6#032F4L36S5W$NPP> I>P\.B:+LI%RM4D!"C
M6\P8D'XV[%':_-)S/3:K+\GM!K^EHQMGHP3CPT'A_%H_"3$4*8VPZ"]ADUSJ
M^1&PO4PHI^3XD-)%#0(E5<G%<@/-2ARC7!\F1 !N4TB=6E=)C)+0!L+^51Z3
M33=&4LN]3V4?JVWXIRULC3Q/=U'.^R6-Z!J3KL4F*/T893YC6\)8W_QVWG^V
M";+Y>!-D;XU^CHZ'_"OV_P-02P$"% ,4    " " 0,-8O2**Q44#  !C"P
M$0              @ $     8V]H<BTR,#(T,#8P,BYX<V102P$"% ,4
M" " 0,-82ZZ%:EH&  "]0P  %0              @ %T P  8V]H<BTR,#(T
M,#8P,E]L86(N>&UL4$L! A0#%     @ @$##6'4N;DF\!   BRH  !4
M         ( ! 0H  &-O:'(M,C R-# V,#)?<')E+GAM;%!+ 0(4 Q0    (
M (! PUB7Y(<=YQP  #2K   .              "  ? .  !D.#0U,3DP9#AK
M+FAT;5!+ 0(4 Q0    ( (! PUBSC?LIU%P  +#X 0 1              "
M 0,L  !D.#0U,3DP9&5X,3 Q+FAT;5!+ 0(4 Q0    ( (! PUBH=Y1V'#<
M /OT   1              "  0:)  !D.#0U,3DP9&5X,3 R+FAT;5!+ 0(4
M Q0    ( (! PUCJ O90PCD  ($$ 0 1              "  5'   !D.#0U
M,3DP9&5X,3 S+FAT;5!+ 0(4 Q0    ( (! PUBOWO=3<Q,  ,P^   1
M          "  4+Z  !D.#0U,3DP9&5X.3DQ+FAT;5!+!08     "  ( /T!
(  #D#0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>d845190d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cohr-20240602.xsd" xlink:type="simple"/>
    <context id="duration_2024-06-02_to_2024-06-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000820318</identifier>
        </entity>
        <period>
            <startDate>2024-06-02</startDate>
            <endDate>2024-06-02</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-387">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-06-02_to_2024-06-02"
      id="Hidden_dei_EntityCentralIndexKey">0000820318</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-398">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-399">2024-06-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-400">Coherent Corp.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-401">PA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-402">001-39375</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-403">25-1214948</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-404">375 Saxonburg Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-405">Saxonburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-406">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-407">16056</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-408">(724)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-409">352-4455</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-410">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-411">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-412">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-413">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-414">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-415">COHR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-416">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-06-02_to_2024-06-02" id="ixv-417">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
